rellease ID

YCO Cloud and Aolani partner to deliver one of the first NVIDIA GB300 NVL72 cluster rollouts in the Philippines

Tue, 29 Sep 2026 08:37:00 +0700

As the country's first renewable-powered Sovereign AI infrastructure, this strategic collaboration aims to foster local innovation and boost the national economy.

SINGAPORE - Media OutReach Newswire - 28 September 2026 - YCO Cloud is proud to announce its collaboration with Aolani and NVIDIA to deliver one of the first NVIDIA GB300 NVL72 cluster deployments in the Philippines.

This collaboration marks a significant milestone, bringing purpose-built sovereign AI infrastructure to the country for the first time.

Designed and implemented to meet global sustainability standards for water usage and dedicated renewable energy sources, the project aims to accelerate and solidify the country's ambitions in sovereign digital capabilities and forward-looking innovation.

Aolani provides AI infrastructure, GPU financing, deployment and operating capabilities; while YCO delivers purpose-built, sustainable and scalable digital infrastructure and local expertise.

By leveraging the combined strengths of YCO Cloud, Aolani, and NVIDIA, this initiative sets the foundation for a scalable, world-class AI ecosystem - accelerating local innovation while driving national economic productivity.

Scheduled for launch in the first quarter of 2027, the initial phase will deploy more than 10,000 NVIDIA Blackwell Ultra GPUs, extending state-of-the-art AI computing infrastructure to local government bodies, domestic enterprise, and local startups, while also attracting innovative global AI native companies.

As part of its commitment to environmental stewardship, YCO Cloud adheres to best practices to meet global standards for energy, water efficiency and environmental sustainability.

"The Philippines is now ready to scale on digital infrastructure with its robust submarine cable systems and growing renewable energy sources. To deliver a product that hasn't been built in the Philippines, we partnered with Science Park of the Philippines Inc. (SPPI), the pioneer and one of the largest industrial park developers in the country, with best-in-country power, water and connectivity infrastructure aligned with our sustainability goals.Our partnerships with Aolani and SPPI complement YCO Cloud's commitment to deliver green digital infrastructure to contribute to the next wave of growth in the country." said Nik de Ynchausti, CEO of YCO Cloud.

Nicholas Chia, CEO at Aolani, said, "As the leading neocloud in Asia, Aolani is committed to delivering high-performance and compliant AI infrastructure at speed and scale to support our customers operating at the forefront of AI innovation. Southeast Asia is fast becoming a key linchpin for global AI infrastructure, and the Philippines is emerging as a dynamic new market for digital infrastructure growth.

This collaboration will play a pivotal role in democratising access to advanced AI infrastructure in the Philippines, supporting the growth of the country's digital economy and AI ecosystem. We are excited to partner with YCO Cloud on this ambitious development to boost infrastructure growth and innovation."

The Philippine government welcomed the news of the partnership. "AI presents significant opportunities for innovation, job creation, and economic growth for the Philippines and Filipinos. We welcome the efforts of homegrown companies like YCO and its Singaporean partner, Aolani.

Anchored on their belief on the country's potential, we appreciate the commitment of both companies to work towards enabling Filipinos to become not just users but also builders and developers of AI. These forward-looking collaborations are key in shaping the Philippines' future and allow us to achieve purposeful progress together," said Leandro Angelo Y. Aguirre, Undersecretary of Department of Information and Communications Technology.

Rosemarie Edillon, Undersecretary of Department of Economy, Planning, and Development, said, "We thank YCO and Aolani for entrusting the Philippines with this significant role in AI infrastructure development. As we enter the Fifth Industrial Revolution, the Philippine Government stands ready to be an active partner in building a trusted, inclusive and ethical AI ecosystem for the Philippines and the world."

YCO Cloud

YCO Cloud's purpose and mission is to deliver sustainable mission-infrastructure designed to drive the Philippines forward. For more information, visit https://www.ycocloud.com/ and follow on YCO Cloud on LinkedIn.

Media Contact

H/Advisors on behalf of Aolani

pr@aolani.com

About Aolani

Where AI gets built in Asia. Founded in 2023, Aolani's AI factories enable enterprises, AI natives, and sovereigns to build with confidence, scale ambitiously, and move at hyper-speed in the world's fastest-growing AI market. Founded in Singapore and backed by compliant and purpose-built neocloud infrastructure, Aolani delivers the performance capabilities for next-generation AI. For more information, visit www.aolani.com and follow @AolaniCloud on LinkedIn.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Aolani

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Tue, 29 Sep 2026 08:31:00 +0700

Industry veteran brings more than two decades of oncology drug discovery leadership to advance Callio's dual-payload ADC pipeline

SAN DIEGO and SEATTLE and SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics ("Callio" or "the Company"), a global, clinical-stage biotechnology company advancing dual-payload antibody-drug conjugates (ADCs) as the next frontier of rationally designed targeted cancer therapy, today announced the appointment of Chris Hassig, PhD, as Chief Scientific Officer (CSO).

Hassig will lead Callio's research and discovery organization, overseeing the advancement of the Company's dual-payload ADC platform and pipeline.

Hassig joins Callio from Boundless Bio, where he served as CSO, building the company's drug discovery organization from its inception through advancement of three internally discovered first-in-class molecules into clinical development. Prior to Boundless Bio, he was CSO of Sierra Oncology (acquired by GSK) and Vice President of Drug Discovery at Sanford Burnham Prebys Medical Discovery Institute. He previously held drug discovery and research roles at Kalypsys, Inc. and the Scripps Research Institute.

"Chris is a highly accomplished oncology drug discovery leader, and I had the privilege of seeing that firsthand," said Zachary Hornby, Chief Executive Officer of Callio Therapeutics. "Over seven years together at Boundless Bio, Chris helped build a discovery engine that took novel biology from concept to clinic. Callio's dual-payload ADC platform is at a similar inflection point, and Chris's experience translating cutting-edge science into differentiated therapeutics makes him the right leader to help us realize our technology's full potential for patients with cancer."

"Callio is pursuing one of the most compelling unmet needs in oncology drug development today by designing ADCs to overcome resistance mechanisms that limit current therapies," said Hassig. "The team has already advanced CLIO-8221 into the clinic and built an ADC platform that systematically tests rationally designed dual-payload combinations for ADCs, optimized for specific tumor targets. I look forward to working with the innovative and talented Callio team to help build and advance a pipeline that can change outcomes for patients who currently have limited options."

Hassig earned a BA in Chemistry and Biochemistry from the University of California, San Diego, and a PhD in Molecular and Cellular Biology from Harvard University. He completed a postdoctoral fellowship at the University of California, Berkeley.

About Callio Therapeutics

Callio Therapeutics is a clinical-stage biotechnology company that is developing dual-payload antibody-drug conjugates (ADCs) as the next frontier of targeted cancer therapy to address high incidence tumors where better therapies are needed. Its proprietary platform pairs modular, adaptable linker technology with rationally selected synergistic payload combinations designed to block key resistance mechanisms that enable cancer's escape.

The Company's lead clinical program, CLIO-8221, is a HER2-targeted dual-payload ADC with potential to prevent and overcome treatment resistance that limits efficacy of current ADCs. Located in San Diego, Seattle, and Singapore, backed by top life science investors, and led by an experienced team with a track record of ADC development and oncology drug approvals, Callio Therapeutics is built to deliver the next generation of dual-payload ADCs and better outcomes for people living with cancer. For more information, visit www.calliotx.com and follow Callio Therapeutics on LinkedIn.

About CLIO-8221

HER2 is a clinically validated target for antibody-drug conjugates (ADCs), with multiple approved therapies demonstrating clinical benefit across tumor types. However, most patients eventually progress on treatment despite their tumors retaining HER2 expression. Mechanistic resistance to cytotoxic payloads has emerged as a key driver of treatment failure. CLIO-8221 is a novel, first-in-class, dual-payload ADC targeting HER2, designed to overcome emergent resistance.

CLIO-8221 delivers two mechanistically complementary payloads, a topoisomerase 1 (Topo1) inhibitor and an ATR inhibitor, directly to HER2-expressing tumors. While Topo1 inhibitors have shown strong clinical activity, activation of the DNA damage response following Topo1 inhibitor-induced replication stress represents a potential major driver of resistance.

By simultaneously inhibiting Topo1 and blocking the DNA damage response through ATR inhibition, CLIO-8221 is engineered to overcome payload insensitivity and further sensitize tumors to Topo1 inhibition. Developed using proprietary linker and ADC platform technologies, CLIO-8221 aims to maximize anti-tumor activity while reducing systemic toxicity, offering the potential for deeper and more durable responses in patients with HER2-expressing tumors.

CLIO-8221 is currently being evaluated in an ongoing Phase 1/2, first-in-human, dose-escalation and expansion study in adult patients with metastatic or unresectable HER2-expressing solid tumors, including those who previously received trastuzumab deruxtecan (T-DXd). The first patient was dosed in March 2026, and enrollment is ongoing in Australia and the US, with plans to open the study in China (NCT07300943).

Dmitry Shubov Consulting Details Corporate Restructuring Roadmap for Inbound Asian Tech Scale-Ups

Tue, 29 Sep 2026 08:27:00 +0700

FREMONT, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Following the September 16, 2026 joint report by Bain & Company, DBS Bank, and Vriens & Partners forecasting 4.8% annual regional growth while noting that tech scale-ups face widening institutional hurdles to capture foreign capital, Dmitry Shubov Consulting has issued a cross-border commercial advisory to guide Southeast Asian technology companies through corporate restructuring and regulatory compliance for U.S. market entry.

The report, From Tailwinds to Trade-Offs: Southeast Asia Outlook 2026-2035, notes that regional firms must establish institutional credibility to attract international capital. To address this structural gap, Dmitry Shubov Consulting developed a commercial advisory framework to address the legal and transactional friction Asian software and legaltech startups encounter when forming American entities, assigning cross-border intellectual property, and navigating U.S. venture capital diligence.

The advisory outlines three operational priorities for founders executing an American expansion:

*Delaware Flip Structuring: Reorganizing domestic operating entities under a U.S. Delaware parent corporation to meet the corporate governance and tax standards typically required by American institutional investors.

*Dual-Jurisdiction IP Assignment: Securing bilateral intellectual property assignments between overseas engineering hubs and the U.S. parent entity to reduce the risk of chain-of-title disputes during institutional diligence.

*CFIUS and Regulatory Alignment: Conducting proactive ownership reviews to help align foreign cap table structures with U.S. Committee on Foreign Investment regulations and federal data security mandates.

"Expanding into the U.S. is rarely a product problem for Southeast Asian founders. The traction is already there. It is usually just an administrative adjustment. American investors are used to very specific corporate setups, so getting your Delaware parent entity and IP assignments squared away early on removes friction and lets the business speak for itself," said Dmitry Shubov, Founder and CEO of Dmitry Shubov Consulting.

Navigating cross-border venture capital and U.S. market entry requires structural alignment well ahead of initial investor discussions. Dmitry Shubov Consulting advises Southeast Asian technology leaders and investor syndicates on structuring market expansions, helping position corporate entities for U.S. capital integration. For more information, please visit dmitryshubovconsulting.com.

About Dmitry Shubov Consulting

At Dmitry Shubov Consulting, our mission is to connect accredited investors with groundbreaking legal technology startups, fostering innovation and growth across Southeast Asia and helping Asian businesses enter the U.S. market. For more information, please visit our website or contact us directly.

Huawei releases world's slimmest and largest foldable smartphone

Tue, 29 Sep 2026 08:21:00 +0700

First smartphone to run HarmonyOS 7 and include chip design breakthrough LogicFolding

SHENZHEN, CHINA - Media OutReach Newswire - 28 September 2026 - Huawei released the HUAWEI Mate XT 2 | ULTIMATE DESIGN trifold smartphone on September 7. The phone is the first to run HarmonyOS 7, and is the slimmest and largest foldable smartphone in the industry. The Mate XT 2's Kirin 9050 chip also includes a major breakthrough in semiconductor design.

As the first smartphone to feature the LogicFolding Tau (τ) Chip, the Mate XT 2 marks the chip's official entry into mass commercialization.

World-class engineering and design

The device is proving popular with consumers due to its foldable wing-like form, which means it can be opened up, transforming the phone into a tablet.

The engineering to make this possible is unprecedented. The glass screen must be tough enough to withstand daily use, whilst being able to fold thousands of times. The hinge to allow the screen to fold is the first of its kind. Once open, the handset is just 3.5mm thick. However, the screen is not the only remarkable folding technology in the device.

The first chip with semiconductor design breakthrough, LogicFolding

The Mate XT 2 Ultimate Design includes a major breakthrough in semiconductor design. The phone is the first to use Huawei's LogicFolding Tau chip Kirin 9050 Pro. Designed by engineers in Huawei's HiSilicon team, the chip offers a solution to the problem of geometric scaling.

With Moore's law (the historical observation that the number of transistors on a microchip doubles approximately every two years) believed to be reaching its physical limit, making chips smaller is becoming more challenging and costly.

For Huawei, faced with external restrictions, the need to find a solution came sooner than expected.

In May this year, He Tingbo, President of Huawei's HiSilicon division, unveiled a new way of designing and making chips, alongside a new law to measure their performance, the τ (Tau) Scaling Law. The work led to Ms He being recently named one of the world's leading AI innovators by Time Magazine.

The point of shrinking transistors was never the smallness itself, it's what the smallness delivered. Shoppers looking to buy the latest smartphone don't care if the chips inside have 7, 5 or even 2-nanometer nodes, they care about the performance of the device in their hands. What matters to consumers is the time it takes for a task to be completed, a video to be shared or a game to load. The performance of the chip should be measured in the same way: by time, not size. This is why Huawei proposed τ (Tau) Scaling Law as an alternative to Moore's Law.

Breaking through barriers to improve performance

The Kirin 9050 Pro uses 3D integration to boost performance. Traditional chip advancement focussed on packing more and more transistors into a linear plain by making each one smaller. LogicFolding uses 3D integration to reduce the distance between transistors by stacking them on top of one another, increasing the number of transistors whilst reducing the distance between them.

In fact, in the Kirin 9050 Pro transistor density has risen from approximately 155 to 238 million transistors per square millimetre. That's an equivalent increase to what was achieved in the previous three years using geometric shrinking.

It was thought that stacking active transistors on top of each other and sealing them inside a solid mobile device would present an engineering challenge. Power turns into heat, which in a confined space would raise the temperature and ultimately break the device.

The key to the solution came in recognising that integrated chips have both transistors and circuits. As He Tingbo explains in her IEEE article, Huawei's τ Chip Was Supposed to Melt?, the inner workings of a chip can be compared to an office worker's day of work. Many office workers will use more energy on their commute to and from the office than they do at their desk because they are moving around more on the road. The 'work' part of their day is not the most energy intensive part as they are often seated at their desk.

The same is true for chips. The most energy intensive part of the process is the 'commute', moving data from point A to point B, not processing it. Integrated circuits use power in two main ways. The first is switching, flipping a transistor gate to change a bit from 0 to 1 and back. The second is the transmission of that data, moving the bits from one part of the chip to another.

This is important in mobile phones where a lot of performance requirements are asked of a single chip. Equally, however, in a large AI cluster 80% of the energy is used in the moving the data, not processing it. In both cases, LogicFolding reduces the space between transistors which in turn reduces the power used. The previous assumption that packing transistors on top of one another would increase the heat turned out to be false. In fact, even with a higher transistor density per millimetre, LogicFolding chips run cooler per unit of work. The result is Huawei's most powerful smartphone ever.

The first phone to run HarmonyOS 7

The Mate XT 2 is the first smartphone to run HarmonyOS 7. Forty-two percent more powerful than the previous generation, it remains the slimmest and largest foldable display in the industry when open. The cover screen spans 6.5 inches, boosting the screen-to-body ratio from 86.4% to 92.8%. Enhanced with 70% better anti-reflection, the screen exhibits a deeper, cleaner black when off, and pure, crystal-clear transparency when lit.

The Huawei Mate XT 2 also introduces the world-first Smart Shield Privacy Screen on a foldable screen. Two independent pixel sets co-exist within the 10.2-inch display at a micro-pitch of just 9 μm. When Privacy Mode is activated, the screen seamlessly switches from a wide viewing angle to a narrow one while maintaining identical resolution and clarity, protecting your privacy in public spaces without compromising your view.

Industry first ECG analysis

Health tech is increasing important to consumers, and so the Mate XT 2 is the industry's first smartphone to introduce ECG analysis. Capitalising on the innovative tri-fold form factor, users can simply hold both side frames with both hands while unfolded to capture a 30-second ECG signal. Paired with the medically certified analysis software, it generates detailed ECG reports to help identify Sinus Rhythm, Atrial Fibrillation, and Premature Beats.

The launch of the Mate XT 2 marks a significant moment in Huawei's journey. The company's R&D has delivered industry leading, and industry changing innovation. More than half of Huawei's employees work in R&D. That's over 100,000 people. The company currently holds 160,000 active patents worldwide. In the first half of 2026 alone, Huawei's R&D investment was over RMB 121 billion, accounting for 25.94% of revenue, up 25.2% year on year.

The HUAWEI Mate XT 2 | ULTIMATE DESIGN starts at RMB 19,999 and is now available for purchase, along with a stylus set, following its official sales launch at 10:08 on September 12th.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Huawei

Future energy solutions take center stage at Monaco Captains' Forum

Tue, 29 Sep 2026 08:16:00 +0700

MONACO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- The transition towards lower-carbon shipping and yachting was at the center of the 31st Captains' Forum at the Yacht Club de Monaco, bringing together captains, shipowners, fleet managers, shipyards, engineers and industry experts to examine the technologies and operational changes shaping the future of maritime energy.

Held under the theme 'Future Energy Sources Onboard Ships and Yachts', the forum, supported by Oceanco, MB92 Group, ICON Yachts and Jutheau Husson, addressed international regulations, alternative fuels, energy efficiency, vessel conversion and emerging propulsion technologies. The discussions highlighted that the energy transition is not based on a single solution, but on a combination of technologies, operational choices and the ability to adapt existing vessels.

The discussions also looked at a broad range of alternative energy sources and fuels, including HVO (hydrotreated vegetable oil), ammonia and hydrogen-derived fuels such as methanol, as well as hydrogen itself. Nuclear power was also discussed as a potential long-term option for certain types of maritime applications, highlighting the wide range of technologies being considered as the industry looks for alternatives to conventional fossil fuels.

Nicolas Millot, Chairman of the France Branch of the Nautical Institute, highlighted the growing regulatory documentation on commercial shipping and the need for the yachting sector - owners and crews - to get ready and work together to reduce emissions. "We need to understand" the regulations, he said, while also looking at measures such as changing fuels, weather routing and adapting vessel operations. For yachts, which are not subject to the same IMO requirements as merchant vessels, voluntary initiatives such as the Yacht Club de Monaco's SEA Index can provide an alternative framework for measuring and improving environmental performance.

The forum also explored the potential of refitting and converting existing vessels rather than building new ones. Marek Hasenkopf, Business Development Manager at Icon Yachts, said an existing vessel can have a "structural and also environmental advantage" over a new build. In one conversion project, 95% of the existing hull and superstructure were reused, representing around 2,900 tons of steel and avoiding the emissions associated with producing new material.

For Jean Guyon, CEO of Aeroforce, the future can go further. "We decided to go very, very far into 100% electric," he said, describing the company's MODX 70 catamaran, which combines solar power, battery storage and automated wing sails capable of generating electricity while sailing.

Technology, however, must also be usable by those operating the vessels. "Captains are very important," Guyon said. "They need to be very confident that it's working" and properly trained to use new systems.

The forum ultimately positioned the energy transition as a collective effort, bringing regulation, technology, shipbuilding and onboard experience together to reduce emissions and support cleaner maritime operations.

Indonesia looks to Monaco to scale up maritime tourism

Tue, 29 Sep 2026 08:09:00 +0700

MONACO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- With more than 17,000 islands, hundreds of ethnic groups and one of the world's richest marine environments, Indonesia sees maritime tourism as a major opportunity for the country's future.

That ambition brought H.E. Widiyanti Putri Wardhana, Minister of Tourism of the Republic of Indonesia, to the Monaco Smart & Sustainable Marina Rendezvous, where she opened the sessions earlier in the week and presented Indonesia's vision for developing a stronger and more sustainable maritime tourism sector.

But the scale of the Indonesian archipelago also creates a complex challenge: developing maritime tourism requires infrastructure, skills, safety standards and a coordinated approach to sustainability across a vast and diverse territory.

"I feel like there is a lot of potential. That's why we are here today to learn from Monaco," the Minister said. For Indonesia, the Monaco event provided an opportunity to explore how an established maritime hub approaches innovation, infrastructure and sustainability. The two-day rendezvous brought together professionals from 30 nationalities and addressed issues ranging from biodiversity and investment to shore power, artificial intelligence, cybersecurity and the transformation of existing marina infrastructure.

Wardhana highlighted human capital development and training as key priorities for international cooperation. But Indonesia's ambitions extend beyond individual marinas, with the country also working towards a broader master plan for maritime tourism that brings together infrastructure, sustainability, safety and professional skills.

"We have a vision to have Indonesia tourism and maritime tourism to be the best destination in Asia," Wardhana said. The country is looking to Monaco as a source of expertise and international connections that could help accelerate the development of its own maritime tourism ecosystem.

"Hopefully, with this transformation and the expertise that we have gained here at the event, we will have a lot of collaboration in training, human capital development in the yachting industry, as well as sustainability efforts, safety, and the creation of a master plan for maritime tourism in Indonesia."

Monaco has positioned itself as a hub for sustainable innovation in yachting, with the Yacht Club de Monaco playing a key role in promoting this vision internationally. For Indonesia, the goal is ultimately to transform its extraordinary maritime resources into high-quality tourism destinations while creating greater benefits for local communities and environment.

For more information:

Press Office LaPresse - ufficio.stampa@lapresse.it

Dusit celebrates Michelin recognition across its global portfolio, led by Two-Key status for flagship Dusit Thani Bangkok

Tue, 29 Sep 2026 07:42:00 +0700

Dusit Thani Bangkok, Dusit's reimagined flagship hotel overlooking Lumpini Park, has been elevated to Two Michelin Keys in the Michelin Guide's 2026 global hotel selection.

Latest Michelin Guide distinctions span hotels and restaurants in Thailand, Japan, the Philippines, and the UAE, reflecting the breadth of Dusit's hospitality offering

BANGKOK, THAILAND - Media OutReach Newswire - 28 September 2026 -Dusit Hotels and Resorts, the hotel arm of Dusit International, one of Thailand's leading hotel and property development companies, is celebrating continued Michelin recognition across its international portfolio, spanning distinctive hotel stays and dining experiences across multiple brands and markets.

Leading the latest honours is Dusit Thani Bangkok, Dusit's reimagined flagship hotel opposite Lumpini Park in the heart of the Thai capital, which has been elevated from One to Two Michelin Keys - denoting an exceptional stay - in the Michelin Guide's 2026 global hotel selection.

Rebuilt on the site of the original hotel, which opened in 1970 and closed for redevelopment in 2019, the 257-room property reopened in September 2024 as a key component of Dusit Central Park, a landmark mixed-use development bringing together the hotel, luxury residences, offices, retail, and an expansive rooftop park.

Conceived to set a new benchmark for the Dusit Thani brand, Dusit Thani Bangkok presents a contemporary interpretation of its predecessor's distinctive identity, with all guest rooms offering sweeping views of Lumpini Park. The hotel reflects a broader evolution of Dusit's luxury offering, centred on combining the group's Thai hospitality heritage with contemporary design and highly personalised service, while shaping each property's experiences around its destination.

This approach is reflected to award-winning effect elsewhere in Dusit's global portfolio. Dusit Thani Kyoto in Japan and Dusit Thani Mactan Cebu Resort in the Philippines have each retained One Michelin Key - denoting a very special stay - maintaining Dusit's Michelin Key presence across three countries while demonstrating how the brand's Thai-inspired gracious hospitality can take distinct forms in different locations.

Beyond its Michelin Key properties, ASAI Bangkok Chinatown, ASAI Bangkok Sathorn, and ASAI Kyoto Shijo - all part of Dusit's locally focused lifestyle brand, ASAI Hotels - are also included in the Guide's curated hotel selection, comprising properties chosen by Michelin's inspectors for their quality, individual character, and connection to their destinations.

Michelin recognition also extends to Dusit's dining experiences. At Dusit Thani Bangkok, Cannubi by Umberto Bombana holds One Michelin Star in the Michelin Guide Thailand 2026 - making it the only Italian restaurant in Thailand to hold the distinction. The contemporary Italian restaurant received its first Star when the 2026 edition was announced in November 2025.

Elsewhere in Bangkok, Thien Duong, the Vietnamese restaurant at Baan Dusit Thani, retains its Michelin Bib Gourmand, recognising good-quality, good-value cooking.

In the Philippines, Benjarong, serving refined Thai cuisine, and Umu, specialising in Japanese dining, at Dusit Thani Manila are both included as Michelin Selected restaurants in the Michelin Guide Philippines 2026.

In the UAE, Namak, serving contemporary Indian cuisine at Dusit Thani Abu Dhabi, continues its run as a Michelin Selected restaurant.

Collectively, the Michelin recognition spans multiple Dusit brands, destinations, and hospitality experiences, from luxury and lifestyle hotels to a diverse range of dining concepts.

"Receiving Two Michelin Keys for Dusit Thani Bangkok is a tremendous honour, and one made even more meaningful by the wider Michelin recognition our hotels and restaurants continue to receive across several destinations," said Chanin Donavanik, Group CEO, Dusit International. "These achievements belong first and foremost to our teams, whose skill, creativity, and care shape the experiences our guests enjoy every day. They also affirm our belief that staying true to our Thai hospitality heritage while continually evolving for the needs of today's travellers can create experiences that resonate far beyond our home market. We are immensely proud of what our teams have achieved, and we will continue building on this foundation across our portfolio."

High-resolution images and a short video accompanying this media release are available here: Dusit celebrates Michelin recognition

For more information about Dusit Hotels and Resorts, please visit dusit.com.

About Dusit Hotels and Resorts

Dusit Hotels and Resorts is the hotel arm of Dusit International. With a heartfelt belief and commitment to introducing Thai-inspired gracious hospitality to the world, Dusit Hotels and Resorts offers guests a uniquely special stay in high-style surroundings and a personalised approach to service. The group's portfolio of hotels, resorts and luxury villas includes close to 300 properties operating under a total of nine brands (Devarana ? Dusit Retreats, Dusit Thani, Dusit Suites, Dusit Collection, Dusit Hotels, dusitD2, Dusit Princess, ASAI Hotels, and Elite Havens) across 19 countries worldwide.

For more information, please visit dusit.com

About Dusit International

Established in 1949, Dusit International is a leading hospitality group listed on the Stock Exchange of Thailand. Its operations comprise five distinct yet complementary business units: Dusit Hotels and Resorts, Dusit Hospitality Education, Dusit Foods, Real Estate Development, and Hospitality-Related Services.

Dusit's diversified investments in real estate development, hospitality-related services, and the food sector are part of its long-term strategy for sustainable growth, which focuses on three key areas: balance, expansion, and diversification.

For more information, please visit dusit-international.com

The issuer is solely responsible for the content of this announcement.

Hashtags: #Dusit

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Tue, 29 Sep 2026 07:29:00 +0700

*Acquisition diversifies durable cash flows and advances Zymeworks' strategy to build a productive R&D company with a growing portfolio of revenue-generating assets

*YUPELRI expected to contribute immediately accretive revenue and cash flow to Zymeworks with base case mid-teens IRR

*Zymeworks to retain existing commercial organization supporting YUPELRI hospital promotion

*The Company expects total revenue, including collaboration revenue from YUPELRI, for 2026 to be between $278 million and $292 million and 2026 Adjusted EBITDA to be between $114 million and $128 million

*Conference call with Zymeworks management today at 8:30 am Eastern Time (ET)

VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the final transaction details and updated financial guidance following the completion of its acquisition of Theravance Biopharma.

The acquisition adds YUPELRI (revefenacin) to Zymeworks' portfolio, providing a durable, recurring source of cash flow to fund the Company's long-term growth strategy. Through Theravance Biopharma's collaboration with Viatris, Zymeworks is entitled to a 35% share of net U.S. profits from YUPELRI and royalties on net sales outside the United States. In the first half of 2026, total YUPELRI sales of $133.1 million resulted in collaboration revenue to Theravance Biopharma of $38.4 million.

"Zymeworks is uniquely positioned to create value from the acquisition through our existing R&D and operational infrastructure, including the ability to leverage the acquired Irish tax attributes alongside our ongoing R&D activities in Ireland, opportunities that are not readily available to traditional royalty-focused buyers," said Scott Platshon, Chief Business Officer at Zymeworks. "We are pleased to welcome the Theravance Biopharma team to Zymeworks and bring together differentiated assets that add meaningful sources of cash flow to our business. We look forward to building on the combined organizations' strengths as we continue to build a durable, diversified business and work to develop innovative medicines for patients with serious diseases."

Commercial Organization and Integration

Zymeworks intends to retain the current commercial organization responsible for YUPELRI sales through the hospital channel. The team brings established commercial capabilities and relationships that Zymeworks believes can support continued growth of the product within the combined organization. The Company plans to hire a seasoned pharmaceutical executive with experience building and leading commercial pharmaceutical organizations to lead the commercial operations of Theravance Biopharma.

In addition, Stuart Knight will become Executive Vice President and Chief Information Officer of Zymeworks, where Stuart will guide the Company's future technology strategy, including continued investment in the Company's existing AI, machine learning, and data science capabilities. Stuart brings substantial experience in biotech and pharmaceutical companies operating in both the United States and Europe. Stuart will also be joined by Jesse Fecker, Ph.D., J.D., who joins Zymeworks as Vice President, Intellectual Property.

"We are very pleased to have Stuart and Jesse join Zymeworks' leadership team as they both bring additional experience and capabilities that will be helpful as we execute against our long-term strategic objectives," said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks.

Zymeworks also retains ownership of Theravance Biopharma's research and development assets, which will be evaluated in the context of the Company's broader pipeline, strategic priorities, and disciplined capital allocation framework. The Company will continue to pursue opportunities to maximize the value of its combined R&D engine through partnerships, collaborations and other strategic structures, including the potential externalization of selected programs where appropriate.

Financial Impact of Theravance Biopharma Acquisition

The acquisition is expected to provide Zymeworks with meaningful and immediate incremental revenue and operating cash flow following closing, including:

Mid-teens base-case IRR, supported primarily by growth in YUPELRI revenues and a smaller contribution from VIBATIV?. This base case does not include potential upside contributions from utilization of tax attributes or future R&D or business development opportunities.

25% growth in YUPELRI hospital sales in the second quarter of 2026, supporting continued margin expansion and increasing operating leverage as net sales continue to scale. Hospital channel growth remains a key driver of the product's continued expansion in the community setting.

Acquisition and restructuring-related costs, excluding capitalized costs attributed to the OMERS Life Sciences (OMERS) non-recourse financing, of approximately $25-30 million

$2.5 billion of Irish tax attributes, which may provide additional flexibility to generate value from future Irish revenues, IP structuring and potential acquisitions or investments through the Company's existing Irish R&D operations. No value has been assigned to the utilization of these tax attributes in the transaction valuation or base case IRR, and any future utilization would therefore represent additional upside.

Potential $100 million TRELEGY ELLIPTA milestone payment expected in the first quarter of 2027, assuming milestone conditions met, offsetting cash outlay for the purchase price.

Transaction Details

Under the terms of the merger agreement announced on June 29, 2026, Theravance Biopharma shareholders received $17.00 in cash at closing for each share of Theravance Biopharma common stock.

The acquisition was financed through a $350 million non-dilutive, non-recourse note from OMERS, in which 75% of the YUPELRI profit-share cash flows are contractually assigned to OMERS to service the associated debt obligations. In addition, approximately $217.5 million of existing cash resources of Zymeworks was used to finance the remaining purchase price, after utilizing the available cash acquired from Theravance Biopharma. The Company expects this net investment to be reduced upon receipt of a potential milestone payment related to TRELEGY ELLIPTA of $100 million expected in the first quarter of 2027.

During the one-year period from closing of this transaction, a designee of Theravance Biopharma will seek to potentially license, divest or otherwise monetize ampreloxetine, with no additional resources expected from Zymeworks. The economics of any such transaction will be shared 20/80 between Zymeworks and Theravance Biopharma shareholders.

Following completion of the transaction, Theravance Biopharma's common stock is no longer listed for trading on the Nasdaq Global Select Market.

Accounting Treatment

The transaction is expected to be accounted for as a business combination. The purchase price will be allocated to the fair value of the net assets acquired and primarily includes rights related to YUPELRI, with any remaining amount recorded as goodwill. YUPELRI is expected to represent the principal identifiable intangible asset and will be amortized over its estimated useful life, generally through the expected loss-of-exclusivity period.

The right to receive a potential milestone payment based on global net sales of TRELEGY ELLIPTA is expected to be recognized as a financial asset at fair value as of the closing date. Assuming the applicable commercial sales milestone is achieved by December 31, 2026, the related milestone payment of $100 million is expected to be collected in the first quarter of 2027.

The Company also expects to recognize a tax liability due to an uncertain tax position as part of the accounting for the business combination. Upon expiration of the applicable audit period in October 2026, the liability may be reversed, resulting in the recognition of a non-cash income tax benefit in the fourth quarter of 2026.

The Company expects to account for the $350 million non-recourse note issued to OMERS as debt using the prospective effective interest rate method. Until the note is repaid, 75% of the YUPELRI profit-share cash flows will be applied to the payment of principal and interest, with the Company retaining the remaining 25%. Following repayment of the note, the Company will retain 100% of the YUPELRI profit-share cash flows.

The preliminary accounting for the transaction will be reflected in the Company's consolidated financial statements in its Form 10-Q for the quarter ending September 30, 2026, which is expected to be filed in November 2026.

Updated Financial Guidance for 2026

With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. Food and Drug Administration approval of Ziihera? (zanidatamab-hrii) for first-line HER2-positive advanced gastroesophageal adenocarcinoma on August 25, 2026, the Company has provided updated financial guidance utilizing relevant financial metrics that it believes provide a more suitable framework for evaluating operating performance of the business.

"The Company expects total revenue for 2026 to be between $278 million and $292 million and 2026 Adjusted EBITDA to be between $114 million and $128 million, excluding the impact of any future transactions," stated Kristin Stafford, Chief Financial Officer of Zymeworks.

"During 2026, we have been able to access a total of $600 million in non-dilutive financing in the form of non-recourse notes at an attractive cost of capital, with proceeds being utilized to fund both the Theravance Biopharma acquisition and continued share repurchases. Our financing strategy and the share repurchase program have focused on minimizing equity dilution to our shareholders. We completed our last public equity offering in January 2022 and have no current plans for additional equity issuances."

Adjusted EBITDA is a non-GAAP financial measure. See "Note Regarding Use of Non-GAAP Financial Measures" below for an explanation of these measures. A reconciliation between GAAP reported and non-GAAP financial information for historical results is provided at the end of this earnings release.

Zymeworks 2026 Share Repurchase Program

In May 2026, the Board of Directors authorized a 2026 share repurchase program under which the Company may repurchase up to $125.0 million of its outstanding common stock, par value $0.00001 per share. As of September 28, 2026, the Company has utilized approximately $49.3 million of this current approved repurchase program to acquire 1,971,454 shares at an average price of $25.04 per share (exclusive of commission expense and estimated excise tax).

Since initiating its share repurchase program in August 2024, the Company has cumulatively utilized $211.6 million to reacquire 10,571,316 shares at an average price of $20.02 per share (exclusive of commission expense and estimated excise tax). As of September 14, 2026, the Company had approximately 71.2 million common shares outstanding.

Investor Call Details

Zymeworks will host a conference call today with investors and the general public at 8:30 am ET. Dial-in details and webcast link are available on Zymeworks' website at https://ir.zymeworks.com/events-and-presentations. A replay of the webcast will be available within 24 hours following the conclusion of the call and will remain archived for a limited period.

About Zymeworks Inc.

Zymeworks is a global biotechnology company building a diversified portfolio of healthcare assets designed to generate durable cash flows while advancing innovative medicines for difficult-to-treat diseases. Zymeworks' asset and royalty aggregation strategy combines a growing portfolio of commercial and near-commercial assets, including YUPELRI (revefenacin), with a differentiated internal research and development engine. Zymeworks' portfolio also includes Ziihera (zanidatamab-hrii), a HER2-targeted bispecific antibody discovered and developed by Zymeworks and commercialized through global partnerships with Jazz Pharmaceuticals and BeOne Medicines, and pasritamig, a clinical-stage multispecific antibody developed by Johnson & Johnson using Zymeworks' proprietary antibody engineering technologies.

Zymeworks is advancing a diverse pipeline of novel biotherapeutics, leveraging its proprietary Azymetric platform and expertise in antibody-drug conjugates, multispecific antibodies and other next-generation antibody technologies. These capabilities, together with Zymeworks' integrated drug development expertise, enable Zymeworks to develop differentiated therapeutics and create value through both internal innovation and strategic partnerships.

For more information about Zymeworks, its portfolio and pipeline, visit www.zymeworks.com and follow @ZymeworksInc on X.

Cautionary Note Regarding Forward-Looking Statements

This press release includes "forward-looking statements" or information within the meaning of the applicable securities legislation, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include, but are not limited to, statements that relate to the anticipated benefits of the acquisition of Theravance Biopharma; the anticipated benefits of the financing in connection with the closing of the acquisition; anticipated milestones payments; Zymeworks' ability to utilize Irish tax attributes; Zymeworks' flexibility to invest in its R&D pipeline and pursue strategic opportunities while returning capital to stockholders; future growth of YUPELRI sales and future royalty payments; sales and future royalty payments related to VIBATIV; contingent milestone payments due to Theravance Biopharma from the sale of Theravance Biopharma's TRELEGY ELLIPTA royalty interests; the repayment of the non-recourse note issued to OMERS Life Sciences; Zymeworks' expectations regarding implementation of its long-term strategy to maximize value creation; Zymeworks' and its partners' clinical development of product candidates; potential safety profile and therapeutic effects of product candidates; the commercial potential of technology platforms and product candidates; the anticipated benefits of its collaboration agreements; the Company's 2026 full year guidance and other information that is not historical information. When used herein, words such as "plan", "believe", "expect", "may", "continue", "anticipate", "potential", "will", "on track", "progress", "preserve", "intend", "could", and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.

All forward-looking statements are based upon Zymeworks' current expectations and various assumptions. Zymeworks believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various factors, including, without limitation: risks related to the financing in connection with the closing of the acquisition; any of Zymeworks' or its partners' product candidates may fail in development, may not receive required regulatory approvals, or may be delayed to a point where they are not commercially viable; uncertainties regarding the commercial success of YUPELRI, TRELEGY and VIBATIV; the anticipated benefits of the acquisition may not be realized or will not be realized within the expected time period; TRELEGY may not achieve anticipated sales resulting in sales milestones not being met; Zymeworks may not achieve milestones or receive additional payments or royalties under its collaborations; regulatory agencies may impose additional requirements or delay the initiation of clinical trials; the impact of new or changing laws and regulations; market conditions, including the impact of tariffs; potential negative impacts of FDA regulatory delays and uncertainty around recent policy developments, changes in the leadership of federal agencies such as the FDA, staff layoffs, budget cuts to agency programs and research, and changes in drug pricing controls; the impact of pandemics and other health crises on Zymeworks' business, research and clinical development plans and timelines and results of operations, including impact on its clinical trial sites, collaborators, and contractors who act for or on Zymeworks' behalf; zanidatamab may not be successfully commercialized; Zymeworks' business strategy related to anticipated and potential future milestones and royalty streams and existing and potential new partnerships may not be successfully implemented; Zymeworks' evolution of its business strategy may not deliver meaningful stockholder returns; Zymeworks may be unsuccessful in actively managing and/or aggregating revenue-generating assets alongside its active R&D operations; ongoing and future clinical trials may not demonstrate safety and efficacy of any of Zymeworks' or its collaborators' product candidates; data providing early validation of our antibody drug conjugate platform and next generation pipeline programs may not be replicated in future studies; Zymeworks' assumptions and estimates regarding its financial condition, future financial performance and estimated cash runway may be incorrect; inability to maintain or enter into new partnerships or strategic collaborations; the inability of Zymeworks to identify and consummate a strategic acquisition; and the factors described under "Risk Factors" in Zymeworks' quarterly and annual reports filed with the Securities and Exchange Commission (copies of which may be obtained at www.sec.gov and www.sedarplus.ca).

Although Zymeworks believes that such forward-looking statements are reasonable, there can be no assurance they will prove to be correct. Investors should not place undue reliance on forward-looking statements. The above assumptions, risks and uncertainties are not exhaustive. Forward-looking statements are made as of the date hereof and, except as may be required by law, Zymeworks undertakes no obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances, or to reflect the occurrences of unanticipated events.

Explanation of Non-GAAP Financial Information

In addition to reporting financial information in accordance with U.S. generally accepted accounting principles (GAAP) in this press release, the Company has elected to present Adjusted EBITDA, a non-GAAP financial measure, on a forward-looking basis. Zymeworks believes Adjusted EBITDA provides useful information regarding the Company's underlying operating performance and facilitates comparisons of operating results across periods.

Adjusted EBITDA should be considered in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. Other companies may calculate Adjusted EBITDA differently or may use other measures to evaluate their performance. Investors and others are encouraged to review Zymeworks' financial information in its entirety and not rely on a single financial measure.

Adjusted EBITDA is calculated as net income (loss), adjusted to exclude income tax expense or benefit, interest income and expense, depreciation and amortization, other non-operating income or expense, share-based compensation expense, and certain other items, including transaction-related costs, restructuring charges and severance costs. A reconciliation of Adjusted EBITDA to net income (loss), its most directly comparable GAAP financial measure, is included in the tables at the end of this press release.

A reconciliation of forward-looking Adjusted EBITDA to the most directly comparable GAAP measures is not available without unreasonable effort due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Accordingly, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, we have not provided a reconciliation of forward-looking Adjusted EBITDA provided in this press release.

For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non-GAAP financial measures that it believes will be achieved; however, it cannot accurately predict all of the components of the adjusted calculations, and the GAAP measures may be materially different than the non-GAAP measures.

Three Months Ended June 30,						Six Months Ended June 30,
		2026			2025			2026			2025

Net income (loss)	$	(45.0	)	$	2.3		$	(89.2	)	$	(20.3	)
Adjustments:
Income tax benefit / (expense)		(0.3	)		(0.2	)		(2.5	)		0.3
Interest expense / (income), net		3.3			(3.4	)		2.7			(6.9	)
Depreciation and amortization		1.1			2.5			2.3			5.1
Other non-operating (income) / expense, net		(0.2	)		0.6			(0.3	)		0.6
Share-based compensation expense		11.3			5.9			18.3			12.3
Transaction-related costs		3.0			?			3.0			?
Restructuring and severance costs		0.1			0.7			3.4			1.2
Adjusted EBITDA	$	(26.7	)	$	8.4		$	(62.3	)	$	(7.7	)

EBC Live Trader Cup Indonesia Kicks Off Amid NFP and FOMC Season

Tue, 29 Sep 2026 07:22:00 +0700

The live account trading competition runs from 28 September to 31 October 2026 and is open to beginner and experienced traders alike, with a minimum starting equity of USD 100.

JAKARTA, Indonesia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) announces the launch of the EBC Live Trader Cup Indonesia, a live account trading competition taking place from 28 September to 31 October 2026.

Under the theme "Buktikan Skill Tradingmu, Rebut Gelar Juara!", this event empowers Indonesian traders to demonstrate and refine their trading expertise in authentic market conditions.

Traders can trade both forex and local favourites such as gold (XAUUSD) and compete for a chance to be among the Top 10 participants, winning from a total prize pool of up to IDR 40 million.

The competition period coincides with a series of US economic releases that often move global markets, especially the gold price. The September Non-Farm Payrolls (NFP) report is scheduled for 2 October, followed by the Consumer Price Index (CPI) inflation data on 14 October. The highlight is the Federal Reserve's Federal Open Market Committee (FOMC) meeting on 27 to 28 October, with the interest rate decision announced in the early hours of 29 October, Western Indonesian Time (WIB).

For gold traders, these market-moving events present an exceptional opportunity to test their skills and strategies. Navigating the volatility brought on by NFP and FOMC releases requires careful preparation, a deep understanding of economic data and its implications, and a disciplined approach to risk management.

An Arena to Test Gold Trading Strategies

Participants are free to apply their own approach. Options range from XAUUSD scalping strategies on lower timeframes and XAUUSD SMC (Smart Money Concepts) strategies, now popular in trading communities, to classic XAUUSD support and resistance analysis. No single XAUUSD timeframe works for everyone; what matters is how consistently traders execute their own plans.

The timing is important as well. Many traders prefer trading gold during the London session, which opens at around 14:00 WIB, or the New York session in the WIB evening, when volume and volatility typically rise. The overlap between the two sessions is often the busiest window for XAUUSD traders in Indonesia.

The competition also addresses a common question among aspiring traders: what is the minimum capital required to start trading gold? Participants can join with a starting capital of USD100. Ranking is based on percentage returns, not total profit. This allows traders with smaller accounts to compete on a level playing field.

The competition also answers a question beginners often ask: what is the minimum capital for gold trading? Participants need only USD 100 in equity to join. Because rankings are based on percentage return rather than nominal profit, small accounts start on equal footing with large ones.

For those just learning how to trade gold, understanding contract size is an important first step. One lot of XAUUSD is generally equivalent to 100 troy ounces of gold, so lot sizing and knowing how to calculate XAUUSD pips largely determine the risk on each position.

Fair for Every Account Size

Rankings are determined by return rate: trading results relative to equity at registration plus deposits made during the competition. Additional deposits mid-competition increase the denominator, so they do not automatically boost a ranking. Withdrawals, on the other hand, do not affect the calculation. All winners must finish with a positive final return.

Every participant will share their trading signals within the EBC copy trading community. This transparent approach enables beginners to observe and learn directly from more experienced traders, especially during pivotal moments such as the NFP and FOMC releases.

"October will be packed with catalysts for the gold market, and that is exactly when a trader's skill shows. Through the Live Trader Cup, we want to provide a fair arena where discipline and strategy matter more than account size," said Fikri Fairuz, Marketing Manager at EBC Financial Group Indonesia.

"We encourage participants to view this competition as a valuable opportunity for growth, skill enhancement, and professional development. In our experience, the most successful traders are defined not by the risks they take, but by their ability to achieve consistent, sustainable growth," he added.

How to Join

Register through the EBC User Portal by clicking "Register Now" on the campaign page. Use a new or existing PRO or STD live account with at least USD 100 in equity, no open positions, and no active copy trades. Each participant may register up to 10 accounts but is eligible for only one prize.

Prizes are USD 1,000 (1st place), USD 500 (2nd), USD 300 (3rd), USD 100 (4th?5th) and USD 50 (6th?10th). They are credited within 30 business days after the competition ends.

Full details at https://ebcidn.com/live-trading/id/

Disclaimer: This material is for information only and does not constitute a recommendation or advice from EBC Financial Group and all its entities ("EBC"). Trading Forex and Contracts for Difference (CFDs) on margin carries a high level of risk and may not be suitable for all investors.

Losses can exceed your deposits. Before trading, you should carefully consider your trading objectives, level of experience, and risk appetite, and consult an independent financial advisor if necessary. Statistics or past investment performance are not a guarantee of future performance. EBC is not liable for any damages arising from reliance on this information.

About EBC Financial Group

EBC Financial Group, headquartered in London, UK, is a comprehensive financial services group licensed and operating in multiple key jurisdictions worldwide. The group offers over 200 Contracts for Difference (CFDs) products, including foreign exchange, precious metals, energy, stock indices, US stocks, ETFs, and cryptocurrencies. With branches in major global financial centres such as Tokyo, Sydney, Singapore, and Hong Kong, its service network covers over 100 countries and regions.

Regulation is the cornerstone of trust in the financial industry. EBC 's various operating entities hold financial regulatory licenses issued by the UK's Financial Conduct Authority (FCA), Australia's Securities and Investments Commission (ASIC), the Cayman Islands Monetary Authority (CIMA), and South Africa's Financial Sector Conduct Authority (FSCA), strictly adhering to local regulatory rules in their operations.

Leveraging its FCA-regulated liquidity access, EBC has established long-term and stable partnerships with over 50 leading banks and non-bank liquidity providers globally. By integrating clearing-grade liquidity quotes, EBC provides clients with direct access to the primary liquidity market, delivering highly competitive institutional-grade liquidity depth and bank-level spreads, allowing clients to easily enjoy extremely low transaction costs. All clients within the group can enjoy top-tier liquidity access through its FCA license; even for offshore accounts, quotes and orders are ultimately processed by a UK company.

Combining big data and AI algorithms to optimize order matching mechanisms, EBC achieves over 87.6% of its orders executed at more favourable prices. For high-frequency and high-volume traders, EBC offers the customized EBC Private Room, a dedicated segregated trading channel that conceals trading orders and avoids market order manipulation. EBC is also one of the few licensed brokers in the industry capable of providing qualified professional investors with FCA liquidity clearing accounts with leverage up to 100x.

The Group's core management team has over 30 years of experience working in large global financial institutions, having gone through multiple complete financial cycles. They have held core management positions in institutions regulated by the FCA, SEC, and CFTC, and their expertise covers key areas such as brokerage business, operations management, compliance and governance, and corporate risk management.

EBC has been named World Finance's "Best Broker in the World" for four consecutive years, earning the trust of over 5 million registered users worldwide. Upholding a long-term perspective, the Group actively fulfils its social responsibilities: as an official partner of FC Barcelona, it collaborates with the University of Oxford's Department of Economics to promote financial education, supports the UN Foundation's "United to Beat Malaria" project, and partners with the World Association of Girl Guides and Girl Scouts (WAGGGS) to advance women's empowerment and social equity.

EBC firmly believes that everyone who trades seriously deserves to be treated seriously.

https://www.ebc.com/

QFC-Kamar Dagang A.S. Berkolaborasi untuk Memperluas Investasi Lintas Negara

Tue, 29 Sep 2026 07:17:00 +0700

DOHA, Qatar dan NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Qatar Financial Centre (QFC), salah satu pusat keuangan dan bisnis onshore (domestik) terkemuka, dan Kamar Dagang A.S. telah menandatangani Nota Kesepahaman (MoU) untuk memperkuat hubungan komersial dan investasi antara Qatar dan Amerika Serikat serta mendukung perusahaan-perusahaan A.S. yang ingin membangun atau memperluas bisnis di Qatar dan kawasan yang lebih luas.

Melalui kemitraan ini, kedua organisasi akan berfokus pada bidang-bidang yang menjadi kepentingan strategis bersama, termasuk pengelolaan kekayaan dan aset, teknologi keuangan, aset digital, dan teknologi untuk perusahaan.

MoU itu ditandatangani dalam diskusi meja bundar eksekutif tertutup yang diselenggarakan bersama oleh QFC dan Kamar Dagang A.S. di New York. Penandatanganan berlangsung pada pekan penting bagi berbagai agenda internasional seputar Forum Ekonomi Qatar dan Pekan Tingkat Tinggi Sidang Majelis Umum PBB (UNGA). Sebagai langkah awal implementasi MoU itu, diskusi meja bundar tersebut mempertemukan para pemimpin bisnis senior A.S. Mereka bertukar pandangan mengenai pertumbuhan regional, ekspansi lintas negara, serta perkembangan aspek regulasi, ekonomi, dan teknologi yang memengaruhi pengambilan keputusan bisnis.

Tn. Mansoor Al Khater, Chief Executive Officer, QFC, mengomentari bagaimana perjanjian itu memperkuat hubungan ekonomi dan komersial yang telah terjalin lama antara Qatar dan Amerika Serikat: "Kemitraan ini bertujuan mengembangkan hubungan kuat antara A.S. dan Qatar menjadi peluang yang lebih besar bagi bisnis di kedua pasar. Kemitraan ini akan membuka lebih banyak jalur untuk berinteraksi sehingga membantu kami untuk lebih baik dalam memahami prioritas perusahaan A.S. dan menghubungkan mereka secara lebih strategis dengan peluang di Qatar."

"Dengan lebih dari 350 perusahaan A.S. yang telah bergabung dalam platform QFC, kami memiliki landasan yang kuat untuk terus berkembang. Tujuan kami adalah mendukung perusahaan A.S. yang ingin memperluas bisnis di kawasan ini dengan menyediakan kepastian regulasi, konektivitas, dan lingkungan bisnis yang mereka perlukan untuk berkembang dengan percaya diri."

Tn. Khush Choksy, Wakil Presiden Senior Hubungan Anggota Internasional dan Timur Tengah, Asia Tengah & Turki, menyampaikan mengenai pentingnya kemitraan ini: "Program Bisnis A.S.-Qatar Kamar Dagang A.S. dengan bangga meresmikan kemitraan ini dengan Otoritas Qatar Financial Centre. Nota Kesepahaman ini mencerminkan komitmen bersama kami untuk memperluas hubungan perdagangan, investasi, dan komersial antara Amerika Serikat dan Qatar. Hal ini menciptakan peluang baru yang nyata bagi bisnis di kedua pasar. Bersama-sama, kami berharap dapat bekerja sama secara erat dengan QFC dalam berbagai program bersama, dialog bisnis, dan inisiatif yang memperkuat salah satu hubungan ekonomi bilateral paling dinamis di kawasan ini."

Tentang Qatar Financial Centre (QFC)

Qatar Financial Centre (QFC) adalah pusat bisnis dan keuangan onshore (domestik) yang berlokasi di Doha, yang menyediakan platform unggulan bagi perusahaan untuk menjalankan bisnis di Qatar dan kawasan sekitarnya. QFC menawarkan lingkungan hukum, regulasi, perpajakan, dan bisnis tersendiri yang memungkinkan kepemilikan asing hingga 100% dan repatriasi keuntungan 100%. QFC juga menerapkan tarif pajak perusahaan kompetitif sebesar 10% atas keuntungan yang bersumber dari dalam negeri. QFC menyambut baik berbagai perusahaan yang bergerak di bidang jasa keuangan maupun nonkeuangan.

@QFCAuthority | #QFCMeansBusiness

Tentang Kamar Dagang A.S.

Kamar Dagang A.S. adalah organisasi bisnis terbesar di dunia yang mewakili perusahaan dari berbagai skala di seluruh sektor ekonomi. Anggota kami mencakup usaha kecil dan kamar dagang lokal yang tersebar di sepanjang Jalan Utama di Seluruh Amerika hingga asosiasi industri terkemuka dan perusahaan besar. Selama lebih dari 114 tahun, kami telah mengadvokasi kebijakan yang mendukung iklim bisnis guna membantu pelaku bisnis menciptakan lapangan kerja dan menumbuhkan perekonomian kami.

Datalec Strengthens its Liquid Cooling Capabilities with the Appointment of Dominik Dziarczykowski

Tue, 29 Sep 2026 07:07:00 +0700

LONDON, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Datalec Precision Installations (DPI), a global provider of integrated data centre delivery solutions, has appointed Dominik Dziarczykowski as Business Development Manager, strengthening the company's expertise in liquid cooling and high-density data centre infrastructure.

Dominik brings more than 20 years of experience across the IT, consulting and data centre industries, with a particular focus on high-density computing, liquid cooling and data centre efficiency.

His career includes experience with organisations including IBM, Dell, Huawei, Deloitte and Capgemini, as well as specialist roles in liquid cooling and data centre infrastructure. He previously worked with CoolIT Systems, where he focused on Direct Liquid Cooling and HPC, and most recently served as Market Development Manager, High Density & Liquid Cooling at Vertiv

At DPI, Dominik will join the Business Development team led by Richard Dobbie, Sales and Marketing Director, supporting customers and partners as Datalec continues to develop its direct liquid cooling capabilities and associated services.

Lee Eiffert, COO at Datalec, highlighted the importance of the appointment: "Dominik brings strong technical and market experience in liquid cooling and high-density infrastructure. We're delighted to welcome him to Datalec and look forward to the value he will bring to our customers and team."

Dominik commented on his appointment: "I'm excited to join Datalec at a time when AI and high-density computing are reshaping data centre infrastructure. I look forward to working with our customers and partners to develop practical liquid cooling solutions."

As a first opportunity to share his expertise in his new role, Dominik will represent Datalec at Data Centre World Asia 2026 in Singapore on 29?30 September, where he will deliver a fireside chat on liquid cooling and the evolving requirements of high-density data centre environments.

About Datalec

Datalec Precision Installations provides world-class, global data centre solutions, specialising in M&E and connectivity design, bespoke manufacturing, construction, modular solutions, installation and data centre services. Supported by unmatched technical expertise we offer consultancy, technical and critical cleaning, electronic security, and managed services to address every data centre need.

Our "One Call, One Team" approach ensures we deliver seamless, end-to-end solutions across the globe, ensuring maximum performance and efficiency. By delivering advanced, future-ready data centres, we empower our clients to embrace and lead the AI revolution. Through our rigorous project management and a proactive, personal and flexible approach, we minimise risks, reduce costs, and deliver tailored solutions that exceed client expectations. Learn more at https://datalecltd.com.

Lanson Place Celebrates Brand's First Michelin Key

Tue, 29 Sep 2026 06:58:00 +0700

Source: Lanson Place Hospitality Management Limited

Lanson Place Parliament Gardens receives prestigious global accolade of One MICHELIN Key as the Melbourne property marks its second anniversary

HONG KONG SAR - Media OutReach Newswire - 28 September 2026 - Lanson Place is delighted to announce that Lanson Place Parliament Gardens in Melbourne has been awarded One MICHELIN Key, the first MICHELIN Key recognition in the brand's history.

MICHELIN defines the One Key accolade as "a very special stay", recognising hotels for the overall experience assessed on design and architecture, service, character, value and contribution to the surrounding destination.

"This first MICHELIN Key marks a meaningful milestone for Lanson Place and serves as a profound recognition of our approach to hospitality," said Michael Hobson, Chief Executive Officer of Lanson Place Hospitality Management. "Our philosophy has always centred on creating a home-away-from-home, somewhere that guests feel a genuine sense of place and belonging. To be recognised by MICHELIN, especially as the Melbourne property celebrates its second anniversary, is a proud moment for our entire organisation and a testament to the dedication of every team member who brings our vision to life."

"Everyone at Lanson Place Parliament Gardens is honoured and proud to be awarded a MICHELIN Key," said Marcus Packham, General Manager ofLanson Place Parliament Gardens. "A beautiful building makes a first impression but it's the people looking after you, and the care they take throughout your stay, that gives a reason to return. This prestigious recognition means a great deal to our team and we are delighted that our work has contributed to such an important milestone for the wider Lanson Place brand."

The first MICHELIN Key for Lanson Place reinforces the brand's commitment to delivering comfortable, distinctive residential-style hospitality which is rooted in each destination.

For more information or to book a stay at Lanson Place Parliament Gardens, visit the hotel website.

About Lanson Place Hospitality Management Limited

Lanson Place is a wholly owned subsidiary of Wing Tai Properties Limited (Wing Tai), a publicly listed company in Hong Kong (HKEx stock code: 369). The transformative hospitality management company currently manages eight properties under the Lanson Place brand, comprising Personal Hotels and Residences in Hong Kong, Shenzhen, Shanghai, Singapore, Kuala Lumpur, Manila and Melbourne. Additionally, it manages Two MacDonnell Road in Hong Kong as well as Yiju Apartment in Shenzhen, China.

Lanson Place provides comfortable, personal sanctuaries for both short-term and extended-stay guests at central locations in major global cities. Infused by a family-like service tradition, Lanson Place creates warm and sheltered places with a club-style feel where communities form and bond. Guests can enjoy a true home-away-from-home experience.

The Group aims to grow the Lanson Place brand across the Asia-Pacific region and continues to explore both investment and management opportunities in major gateway cities.

Website: lansonplace.com

Social Media IG: @lansonplace / FB: @LansonPlacePersonalHotels&Residences

The issuer is solely responsible for the content of this announcement.

Hashtags: #LansonPlace #MICHELINKey #LansonPlaceParliamentGardens

https://www.lansonplace.com/

https://www.facebook.com/lansonplace/

https://www.instagram.com/lansonplace/

MIMS Accelerates Product Innovation and International Growth

Mon, 28 Sep 2026 09:11:00 +0700

Issuer: MIMS Pte Ltd

Launch of new products, market expansion and AI-enabled capabilities mark the next stage of growth for a global healthcare

technology company anchored by six decades of trusted medical data and expertise.

SINGAPORE - Media OutReach Newswire - 28 September 2026 - MIMS Group, an Asia-Pacific provider of medicines information, clinical decision support, medical communications and marketing services, is accelerating product innovation and international growth as it transforms its long-standing healthcare data, content and market expertise into new technology platforms, customer applications and services.

Following the appointment of Sohil Goswami as Group CEO in January 2026, MIMS has reshaped its businesses and leadership structure to support its next phase of growth.

The company is now ready to harness its data, technology and healthcare relationships to create scalable products and new business models across markets.

Clinical Decision Support expands across products and markets

MIMS recently launched MIMS Pulse, its next-generation Clinical Decision Support platform that combines MIMS' medicines data and clinical knowledge with modern technology, flexible deployment and integration capabilities to support safer and more efficient clinical workflows.

Alongside MIMS Pulse, the company is scaling eMIMS Plus, a platform that brings MIMS' trusted medicines information into a modern digital experience designed to achieve quality use of medicine. Conceived and first launched in Australia under Goswami's guidance in his previous role leading the CDS Business, eMIMS Plus is now available in India and Malaysia with plans to expand across Southeast Asia, introduce new clinical modules, as well as extend into new healthcare categories through Drugs4Dent.

MIMS is developing its global CDS offering, building on MIMS Pulse and eMIMS Plus to take its clinical data and technology capabilities into new markets and customer environments.

Medical Marketing business transforms for global growth

MIMS' Medical Communications business is expanding internationally, with commercial capabilities in the US and UK creating opportunities with new client segments and global life sciences organisations. The business continues to develop digital events, AI-enabled content capabilities and new customer engagement models.

MIMS is exploring more connected, intelligence-led services - helping healthcare and life sciences organisations better understand their markets, engage healthcare professionals and make more informed decisions.

This work represents an important step beyond MIMS' traditional information and communications models, applying its content data and market reach to new technology-enabled services.

Goswami said:

"For decades, healthcare professionals have trusted MIMS' medicines information and expertise. Today, we are transforming that foundation into the next generation of digital products, platforms and services.

We have been reshaping the business ? bringing our capabilities together, strengthening our technology and building new ways to serve customers across markets.

Our opportunity is to turn trusted medical data, deep healthcare relationships and market knowledge into the next generation of products, platforms and services to build a MIMS that can compete and grow globally while staying relevant to the markets we serve."

The developments form part of a broader evolution across MIMS as the company builds on its established strengths while extending its products, capabilities and reach into new areas of healthcare.

Hashtag: #MIMS #MIMSPulse #eMIMSPlus #clinicaldecisionsupport #medicalmarketing #AIinhealth #digitalhealth #healthcareinnovation #healthtech #HCP

About MIMS: Empowering Healthcare Communities to Improve Patient Outcomes

MIMS is Asia's largest multi-channel provider of drug information, medical communications, events management, marketing, and recruitment services. Established in 1963, our work empowers healthcare professionals to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 17 markets globally with over two million healthcare professional subscribers to our drug & resource portal, digital and print publications.

Combining healthcare communications expertise with our established networks and presence in the Asian healthcare community, we enable clients to engage their stakeholders in meaningful dialogue through a range of medical and marketing communications services.

We facilitate long-term placement of nurses, pharmacists and doctors across the globe to match the demands of healthcare institutions looking for high-calibre practitioners.

MIMS has offices in the following global markets:

Singapore (headquarters), Australia, China, Germany, Hong Kong SAR, Indonesia, India, Ireland, Japan, Korea, Malaysia, New Zealand, Philippines, Taiwan, Thailand, UAE, Vietnam

Learn more at https://corporate.mims.com/ or follow https://www.linkedin.com/company/mims-pte-ltd/

The issuer is solely responsible for the content of this announcement.

New iGarden K70 AI Pool Cleaner Launches in Australia: Smart Pool. Smarter Backyard.

Mon, 28 Sep 2026 08:49:00 +0700

Issuer: Fairland Group

SYDNEY, AUSTRALIA - Media OutReach Newswire - 28 September 2026 - Fairland Group's outdoor technology division, iGarden, announced the launch of the iGarden K70 AI Pool Cleaner, bringing extended runtime and whole-pool cleaning to Australian backyards. The K70 will be available for purchase in Australia starting September 30, 2026, at AUD $1,599 through the iGarden Official Store.

New iGarden K70 AI Pool Cleaner Launches in Australia

As Australia moves into the warmer months, backyard pools become popular spaces for swimming, family time and weekend entertaining. Keeping them clean, however, can mean frequent manual maintenance as leaves, dust and other outdoor debris accumulate. The K70 is designed to automate more of that routine work, giving homeowners more time to enjoy their outdoor spaces.

Up to 16 Days of Cleaning on a Single Charge

Powered by AI-Inverter technology, the K70 intelligently adjusts its operating power according to pool conditions and delivers up to 16 days of cleaning on a single charge. Its extended runtime reduces the need for frequent charging and hands-on intervention during the swimming season.

Whole-Pool Cleaning, From Waterline to Steps

The K70 is engineered to clean across the waterline, pool floor, walls, and steps. Its intelligent navigation helps the cleaner move across different pool surfaces, providing more comprehensive coverage for residential pools.

Powerful Pickup and Dual-Layer Filtration

The K70 combines Turbo 200% technology with a water flow of up to 22,000 LPH to tackle a wide range of pool debris, from large debris like leaves to fine particles. A 180 μm + 50 μm dual-layer filtration system helps capture debris across different particle sizes, while its 4-litre debris capacity allows for longer cleaning sessions with fewer interruptions to empty the collection basket.

Simple Touchscreen Control

An integrated touchscreen interface provides intuitive control directly on the device, bringing advanced pool-cleaning technology into a straightforward user experience. With long-lasting power, whole-pool coverage and high-capacity debris collection, the K70 is designed around a simple idea for Australian homeowners: less time cleaning the pool, more time enjoying the backyard.

Availability

The iGarden K70 AI Pool Cleaner is priced at AUD $1,599, with sales in Australia beginning September 30, 2026, via the iGarden Official Store.

Hashtag: #TheiGardenK70AIPoolCleaner

About iGarden

Focused on AI-powered outdoor technology, iGarden develops pool cleaners, swim jets, smart lawn mowers, pumps, and AIoT systems.

The issuer is solely responsible for the content of this announcement.

EBANX and NetEase Games Club bring local payment methods to Latin America's booming video game market

Mon, 28 Sep 2026 08:44:00 +0700

Issuer: EBANX

Partnership unlocks card and local payment options for players in Brazil, Mexico, Argentina, Chile, and Peru as the region's gaming revenues outpace mature markets

SINGAPORE / GUANGZHOU, CHINA - Media OutReach Newswire - 28 September 2026 - Latin America is one of the fastest-growing video game markets in the world, yet millions of its players have long faced barriers to purchasing content because of how they pay.

EBANX, a global technology company specializing in cross-border payments for emerging markets, and NetEase Games Club, the official top-up destination for NetEase Games titles, today announced a partnership to expand payment access for players across the region.

Through this collaboration, NetEase Games Club will, in its initial rollout, offer players across Brazil, Mexico, Argentina, Chile, and Peru access to the region's widely used local payment methods alongside credit and debit cards. Supported methods include Pix in Brazil, SPEI in Mexico, PagoEfectivo in Peru, and the digital wallet Mercado Pago across the region.

In Latin America, only one in four adults has a credit card, while more than half of the population aged 15 and older has already made a digital payment, according to World Bank data. For those without access to credit cards, this payment gap is increasingly being filled by local payment methods, including those now available to NetEase Games Club through EBANX.

Reaching players where cards don't

In Brazil, the instant payment system Pix is used by around 170 million people, equivalent to 96% of the adult population, while around 60 million Brazilians do not have a credit card. In Mexico, only 33% have access to one, in a country where more than half of adults use the account-to-account payment system SPEI. In Peru, 37% of adults have a credit card, yet the cash-based PagoEfectivo reaches 64% of the adult population.

The commercial impact of closing that gap is well established. For EBANX merchants, integrating Pix has driven revenue uplifts of up to 37% within six months. Adding SPEI in Mexico has produced increases of up to 46% within three months and PagoEfectivo in Peru up to 19% within one month.

"The next wave of video game growth is coming from emerging markets, and Latin America is leading it," said Sean Yu, VP of Commercial for APAC at EBANX. "By combining cards with the local payment methods players actually use, NetEase Games Club is building a truly localized checkout experience, and unlocking access to a much larger share of the region's revenue potential."

A market outpacing mature regions

The five markets covered by the partnership between NetEase Games Club and EBANX are expected to generate USD 8.4 billion in video game revenues in 2026, according to Payment and Commerce Market Intelligence (PCMI) data analyzed by EBANX. Brazil, the region's largest market, is projected to reach USD 3.8 billion this year.

The Latin American video game market grew 6.4% in 2025, according to Newzoo's latest report, outpacing North America (+4.2%) and Europe (+3.6%). The region is home to 372.3 million gamers, with 69% of its online population playing games on at least one platform.

The infrastructure connecting APAC to Latin America

The partnership reflects an accelerating movement of APAC companies expanding into Latin America, driven by market saturation at home and the search for new growth corridors. EBANX has operated at the center of this dynamic for years, with an APAC headquarters in Singapore, an office in Shanghai, and a track record serving global video game leaders across more than 20 markets in Latin America, Africa, and Asia.

The company recorded 48% growth in total payment volume (TPV) in 2025, a record in its history, with APAC merchants contributing to that expansion as they increased their presence in Latin American markets. EBANX holds a Major Payment Institution (MPI) licence in Singapore and provides Chinese and broader APAC companies a single, compliant entry point into those markets.

Hashtag: #EBANX #NetEase #Fintech #Payments #Gaming #LatinAmerica

ABOUT EBANX

EBANX is the leading technology platform connecting global businesses to the world's fastest-growing digital markets. Founded in 2012 in Brazil, EBANX was built with a mission to expand access to international digital commerce. Leveraging proprietary technology, deep market expertise, and robust infrastructure, the platform enables global businesses to offer hundreds of local payment methods and streamline cross-border payments across Latin America, Africa, and Asia.

With a global footprint, it established a technology and regulatory headquarters in Singapore in 2026. More than just payments, EBANX drives growth, enhances sales, and delivers seamless purchase experiences for businesses and end users alike.

For further information, please visit:

Website: https://www.ebanx.com/en/

LinkedIn: https://www.linkedin.com/company/ebanx

ABOUT NETEASE GAMES

NetEase Games, the online games division of NetEase, Inc. (NASDAQ: NTES and HKEX: 9999), is a leading global developer and publisher of video game IP across a variety of genres and platforms. NetEase Games' development and publishing slate includes titles such as Marvel Rivals, Where Winds Meet, Knives Out and Naraka: Bladepoint, and partnerships with major entertainment brands such as Warner Bros and Mojang AB (a Microsoft subsidiary).

For more information, please visit: https://www.neteasegames.com/

ABOUT NETEASE GAMES CLUB

NetEase Games Club is the official top-up destination for players worldwide, offering recharges and in-game items for Marvel Rivals, Where Winds Meet, Once Human, Knives Out, Identity V, and more - delivered directly to your account. Pay by credit card, local wallet, bank transfer, or NetEase Pay gift card through a secure checkout. Members earn points on every purchase and unlock exclusive rewards through GamesClub Membership.

For more information, please visit: pay.neteasegames.com

The issuer is solely responsible for the content of this announcement.

Usai Geger Kenaikan BBM, Pertamina Jamin Pasokan Aman dan Sesuai Harga Resmi

Mon, 28 Sep 2026 08:37:00 +0700

NASIONAL, MIGAS, - Pihak PT Pertamina Patra Niaga turut memastikan operasional penyaluran bensin di seluruh Stasiun Pengisian Bahan Bakar Umum (SPBU) berjalan normal.

Konsumen diimbau tidak melakukan panic buying dan selalu memverifikasi pembaruan harga resmi melalui aplikasi MyPertamina atau kontak Pertamina 135.

Rincian Harga BBM Pertamina Tanggal 27 September 2026.

Sebagai acuan, berikut daftar harga resmi BBM di wilayah DKI Jakarta dan sekitarnya (harga BBM non-subsidi sempat mengalami penyesuaian di awal September)

? Pertalite (Subsidi): Rp 10.000 per liter

? Bio Solar (Subsidi): Rp 6.800 per liter

? Pertamax: Rp 15.950 per liter

? Pertamax Green 95: Rp 19.150 per liter

? Pertamax Turbo: Rp 19.600 per liter

? Dexlite: Rp 23.700 per liter

? Pertamina Dex: Rp 25.200 per liter

Masyarakat diharapkan tetap tenang, selektif dalam membagikan informasi di media sosial, dan hanya memercayai rilis resmi dari pemerintah atau saluran berita di percaya. **

Hiruk Pikuk Kabar Isu BBM Naik September 2026 ini

Mon, 28 Sep 2026 07:30:00 +0700

JAKARTA - Media sosial belakangan ini dihebohkan oleh peredaran infografis dan poster digital yang mengklaim bahwa harga BBM bersubsidi jenis Pertalite akan mengalami kenaikan drastis.

Dalam narasi yang beredar secara masif di platform seperti Threads, Facebook, dan TikTok tersebut, disebutkan bahwa Menteri ESDM Bahlil Lahadalia resmi mengumumkan penyesuaian harga Pertalite dari Rp 10.000 menjadi Rp 13.500 per liter mulai 26 September 2026 dengan alasan lonjakan harga minyak dunia.

Namun, masyarakat diminta untuk tidak panik dan tidak menyebarkan lebih lanjut informasi menyesatkan tersebut.

Bantahan Resmi Kementerian ESDM

Merespons isu liar ini, Juru Bicara Kementerian ESDM, Dwi Anggia, langsung memberikan klarifikasi resmi.

"Perlu kami luruskan, saat ini masif sekali konten media sosial yang berisikan informasi kenaikan harga Pertalite. Konten atau informasi ini adalah hoaks atau berita bohong," ujar Dwi Anggia kepada media.

Senada dengan hal itu, Sekretaris Jenderal Kementerian ESDM, Ahmad Erani Yustika, menegaskan kembali bahwa komitmen pemerintah belum berubah. Sesuai arahan Menteri ESDM Bahlil Lahadalia, harga BBM bersubsidi seperti Pertalite dan Biosolar dijaga agar tidak naik guna mempertahankan daya beli masyarakat.

"Pokoknya enggak ada ini, enggak ada, enggak ada perubahan, kan sudah. Pak Menteri sudah menyampaikan itu semua," jelas Erani di kantor Kementerian ESDM, Jakarta.

Pertamina Jamin Pasokan Aman

Di sisi operasional, PT Pertamina Patra Niaga juga memastikan pendistribusian Pertalite berjalan normal di seluruh SPBU Indonesia sesuai ketentuan dan harga resmi yang berlaku. Manajemen Pertamina mengimbau konsumen agar selalu memverifikasi info harga BBM secara berkala langsung melalui aplikasi resmi MyPertamina atau website resmi perusahaan.

Daftar Harga BBM Pertamina Hari Ini (September 2026)

Sebagai referensi, berikut adalah harga resmi BBM komoditas subsidi dan beberapa jenis non-subsidi utama yang berlaku saat ini (bervariasi tipis di beberapa daerah karena faktor pajak bahan bakar/PBBKB):

Jenis BBM	Kategori	Harga per Liter
Pertalite	Subsidi	Rp 10.000
Biosolar	Subsidi	Rp 6.800
Pertamax	Non-Subsidi	Rp 12.000 - Rp 12.500 (tergantung wilayah)

Masyarakat diimbau agar lebih bijak menyaring informasi dari media sosial serta tidak melakukan pembelian secara berlebihan (panic buying) karena pasokan BBM dalam kondisi aman dan harga Pertalite tetap stabil. (*)

GTCFX Sukses Berpartisipasi di Forex Expo Dubai 2026

Sun, 27 Sep 2026 08:12:00 +0700

DUBAI, Uni Emirat Arab, Sept. 27, 2026 (GLOBE NEWSWIRE) -- GTCFX berhasil merampungkan partisipasinya di Forex Expo Dubai 2026 yang digelar pada tanggal 22?23 September di Dubai World Trade Centre.

Selama dua hari penyelenggaraan acara, pengunjung bertemu dengan tim GTCFX di Hall 2, Stan 54. Di sana, mereka mempelajari lebih lanjut beragam solusi trading perusahaan yang berada di bawah pengawasan berbagai otoritas regulator. Pengunjung juga mengenal fitur trading melalui perangkat seluler, serta komitmennya terhadap edukasi nasabah.

Teks Alternatif: GTCFX di Forex Expo Dubai 2026

Salah satu sorotan dalam ajang tersebut adalah keberhasilan GTCFX meraih penghargaan Aplikasi Trading Valas Seluler Terbaik. Pencapaian tersebut melengkapi presentasi GTC Go App yang ditampilkan perusahaan dalam pameran tersebut. Hal ini sekaligus mencerminkan komitmen berkelanjutan perusahaan untuk memudahkan trader dalam mengakses pasar keuangan global.

GTCFX juga turut berkontribusi dalam program edukasi di pameran tersebut melalui presentasi terbuka yang disampaikan oleh Jameel Ahmed, Kepala Analis GTCFX. Dalam sesi bertajuk "Tren Trading yang Patut Dicermati pada Kuartal IV 2026," Ahmed mengulas berbagai perkembangan yang memengaruhi pasar global. Presentasi tersebut membahas risiko geopolitik, ekspektasi inflasi, dan perubahan prospek suku bunga, serta potensi dampaknya terhadap harga minyak, dolar AS, emas, dan nilai tukar USD/JPY.

Presentasi lanjutan memperkenalkan merek GTC dan menyoroti pentingnya edukasi investor di tengah kondisi pasar yang semakin dipengaruhi oleh perkembangan politik dan arus informasi yang bergerak cepat. Presentasi tersebut juga menyoroti semakin kuatnya kehadiran GTCFX di Dubai, termasuk pengembangan GTC Tower sebagai kantor pusat global perusahaan.

Forex Expo Dubai 2026 memberikan kesempatan bagi GTCFX untuk berinteraksi langsung dengan trader, mitra, dan profesional di industri ini. Dalam ajang tersebut, GTCFX juga memaparkan wawasan terkini mengenai pasar serta solusi trading digitalnya.

Setelah sukses berpartisipasi dalam acara yang berlangsung selama dua hari di Dubai, GTCFX berharap dapat terus mengembangkan hubungan yang telah terjalin selama pameran tersebut. Perusahaan juga akan terus mendukung komunitas globalnya melalui edukasi pasar, teknologi, dan solusi trading yang mudah diakses.

Tentang GTCFX:

GTCFX merupakan penyedia layanan keuangan global yang menawarkan akses ke berbagai pasar keuangan melalui teknologi trading canggih dan solusi yang berfokus pada kebutuhan nasabah. Sejak tahun 2012, GTCFX telah melayani nasabah di lebih dari 100 negara dan wilayah, dengan fokus berkelanjutan pada transparansi, inovasi, dan praktik trading yang bertanggung jawab.

YYForce Mengumumkan Hasil Keuangan Semester Pertama 2026, yang Menyoroti Pertumbuhan Pendapatan sebesar 26,8% menjadi US$32,7 Juta

Sun, 27 Sep 2026 07:59:00 +0700

Pendapatan dari Outsourcing Tenaga Kerja Naik 62,4% menjadi US$15,6 Juta; Pendapatan dari Manajemen Fasilitas Terintegrasi (IFM) Naik 11,1% menjadi US$16,1 Juta

Rugi Bersih Menyusut 13,8% Dibandingkan Tahun Sebelumnya

Modal Kerja Naik menjadi US$11,9 Juta dari Defisit US$1,7 Juta pada Akhir Tahun 2025; Total Liabilitas Turun 39%

SINGAPURA, Sept. 26, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (Nasdaq: YFOR) ("YYForce" atau "Perusahaan," sebelumnya bernama YY Group Holding Limited (Nasdaq: YYGH)), penyedia platform manajemen tenaga kerja berkemampuan AI dan manajemen fasilitas terintegrasi (IFM) yang beroperasi di Asia dan wilayah lainnya, hari ini mengumumkan hasil keuangan yang belum diaudit untuk periode enam bulan yang berakhir pada 30 Juni 2026.

YYForce membukukan pendapatan sekitar US$32,7 juta pada semester pertama 2026, naik 26,8% dari US$25,8 juta pada periode yang sama tahun 2025. Perusahaan memandang ekspansi berkelanjutan bisnis tenaga kerja dan IFM sebagai landasan operasional bagi "Visi YYForce 2030". Strategi jangka panjang ini bertujuan untuk membangun ekosistem tenaga kerja terintegrasi yang menghubungkan tenaga kerja manusia, kecerdasan buatan ("AI"), robot humanoid, dan robot layanan khusus.

Ikhtisar Kinerja Keuangan Semester Pertama 2026

Pendapatan meningkat 26,8% dibandingkan tahun sebelumnya dari US$25,75 juta menjadi US$32,66 juta.

Pendapatan dari outsourcing (alih daya) tenaga kerja meningkat 62,4% dibandingkan tahun sebelumnya menjadi US$15,55 juta.

Pendapatan dari IFM meningkat 11,1% dibandingkan tahun sebelumnya menjadi US$16,06 juta.

Laba kotor tercatat sebesar US$3,30 juta dengan margin laba kotor sebesar 10,1%, turun dari laba kotor sebesar US$4,27 juta dengan margin laba kotor 16,6% pada periode yang sama tahun sebelumnya. Penurunan tersebut terutama disebabkan oleh biaya tenaga kerja yang lebih tinggi.

Rugi operasional menyusut 32,2% dibandingkan tahun sebelumnya, dari US$7,68 juta menjadi US$5,21 juta. Penurunan ini terutama disebabkan oleh tidak adanya rugi penurunan nilai aset tak berwujud sebesar US$4,06 juta yang sebelumnya tercatat pada periode yang sama tahun lalu.

Rasio rugi operasional terhadap pendapatan turun dari 29,8% pada periode yang sama tahun sebelumnya menjadi 15,9%.

Rugi bersih menyusut 13,8% dibandingkan tahun sebelumnya, dari US$8,20 juta menjadi US$7,06 juta.

Rugi operasional non-IFRS tercatat sekitar US$2,74 juta, sedangkan rugi non-IFRS tercatat sekitar US$3,29 juta.

Kas tercatat sekitar US$3,08 juta per 30 Juni 2026.

Total ekuitas naik dari US$13,61 juta per 31 Desember 2025 menjadi sekitar US$25,36 juta. Peningkatan ini terutama didorong oleh perolehan dana sebesar US$18,55 juta melalui mekanisme penawaran saham At-The-Market (ATM).

Total liabilitas turun dari US$20,73 juta per 31 Desember 2025 menjadi sekitar US$12,66 juta. Penurunan ini terutama disebabkan oleh pelunasan utang usaha dan utang lainnya serta berkurangnya liabilitas waran.

Ikhtisar Kinerja Operasional Semester Pertama 2026:

	Untuk Periode Enam Bulan yang Berakhir pada 30 Juni,
	2026		2025
Layanan Tenaga Kerja
Jumlah unduhan Aplikasi YY Circle (Kumulatif)	998.575		586.389
Jumlah pengguna aktif bulanan Aplikasi YY Circle	35.743		30.103
Tingkat pemenuhan pekerjaan	92	%	93	%
Jumlah Pemberi Kerja	212		203

Layanan IFM
Jumlah pelanggan	218		190
Pendapatan rata-rata per pelanggan	73.682		76.095

Komentar Manajemen

Mike Fu, CEO YYForce, berkomentar: "Kami mencapai pertumbuhan pendapatan sebesar 26,8% dibandingkan tahun sebelumnya. Pertumbuhan ini didorong oleh kenaikan pendapatan dari outsourcing tenaga kerja sebesar 62,4% serta ekspansi berkelanjutan operasi IFM kami. Selain mengembangkan bisnis layanan yang sudah ada, kami juga membangun fondasi untuk mewujudkan lingkungan kerja masa depan yang memungkinkan manusia, kecerdasan buatan, fasilitas pintar, otomatisasi, dan robotika untuk semakin bekerja sama. Kami sedang menguji coba robot layanan dan berencana menerapkan alur kerja berbasis agen AI pertama kami serta meluncurkan laboratorium data pelatihan AI. Langkah awal ini mengarah pada sistem operasional yang memungkinkan setiap tugas ditangani oleh manusia atau teknologi yang paling sesuai. Sementara itu, bisnis tenaga kerja dan IFM kami yang terus berkembang menyediakan hubungan dengan pelanggan, infrastruktur tenaga kerja, fasilitas, serta lingkungan operasional nyata yang diperlukan untuk memvalidasi dan mengomersialkan teknologi tersebut. Menjelang 2030, kami berharap YYForce dapat berkembang dari penyedia layanan padat karya menjadi penyedia layanan tenaga kerja terintegrasi yang siap menghadapi masa depan. Kami akan berfokus pada peningkatan margin, efisiensi operasional, dan alokasi modal yang disiplin untuk menciptakan nilai bagi para pemangku kepentingan kami."

Jason Phua, CFO YYForce, menambahkan, "Pertumbuhan pendapatan pada periode ini diiringi penurunan margin laba. Upah per jam pekerja lepas meningkat lebih cepat dibandingkan tarif yang kami kenakan kepada pelanggan. Akibatnya, margin laba kotor kami menyusut dari 16,6% menjadi 10,1%. Kami menangani masalah ini secara langsung dengan menyesuaikan tarif kontrak saat diperpanjang serta menegosiasikan ulang atau mengakhiri kontrak yang tidak lagi mampu menutupi biaya. Kami juga memperketat penjadwalan untuk mengurangi jam kerja yang tidak ditagihkan serta mengevaluasi solusi berbasis teknologi, digital, dan otomatisasi guna meningkatkan produktivitas. Kami juga memperbaiki struktur permodalan dan posisi modal kerja. Pada akhir semester pertama 2026, kami membukukan modal kerja sebesar US$11,9 juta, dibandingkan dengan defisit pada akhir 2025, sekaligus mengurangi total liabilitas sebesar 39%. Pemulihan margin laba kotor menjadi prioritas kami pada semester kedua 2026, dan kami akan melaporkan perkembangannya dalam laporan hasil keuangan tahunan."

Hasil Keuangan Semester Pertama 2026

Total Pendapatan mencapai US$32,7 juta pada semester pertama 2026, naik 26,8% dari US$25,8 juta pada periode yang sama tahun 2025.

Pendapatan dari outsourcing tenaga kerja meningkat 62,4% dari US$9,58 juta pada periode yang sama tahun 2025 menjadi US$15,55 juta. Peningkatan ini terutama didorong oleh kenaikan permintaan pelanggan di Singapura dan Malaysia serta kontribusi dari anak perusahaan kami di Hong Kong dan Thailand.

Pendapatan dari IFM naik 11,1% dari US$14,46 juta pada periode yang sama tahun 2025 menjadi US$16,06 juta. Pertumbuhan ini didukung oleh perolehan kontrak baru, perpanjangan proyek yang sudah ada, serta kontribusi sepanjang periode dari anak perusahaan yang diakuisisi pada tahun 2025, termasuk Property Facility Services Pte. Ltd. dan Uniforce Security Services Pte. Ltd.

Laba kotor tercatat sekitar US$3,30 juta, dibandingkan dengan US$4,27 juta pada semester pertama 2025. Margin laba kotor tercatat sekitar 10,1%, dibandingkan dengan 16,6% pada periode yang sama tahun sebelumnya. Penurunan ini terutama disebabkan oleh kenaikan biaya tenaga kerja di seluruh bisnis IFM dan outsourcing tenaga kerja Perusahaan, termasuk kenaikan tarif upah per jam bagi pekerja lepas.

Rugi operasional menyusut 32,2% dari US$7,68 juta pada periode yang sama tahun 2025 menjadi sekitar US$5,21 juta. Penurunan ini terutama disebabkan oleh tidak adanya rugi penurunan nilai aset tak berwujud sebesar US$4,06 juta yang sebelumnya tercatat pada semester pertama 2025. Rasio rugi operasional terhadap pendapatan turun menjadi sekitar 15,9%, dibandingkan dengan 29,8% pada periode yang sama tahun 2025.

Rugi bersih turun 13,8% dari US$8,20 juta pada periode yang sama tahun sebelumnya menjadi sekitar US$7,06 juta. Rugi per saham biasa, baik dasar maupun dilusian tercatat sebesar US$13,62, dibandingkan dengan US$311,00 pada semester pertama 2025. Seluruh jumlah saham dan nilai per saham telah disesuaikan secara retroaktif untuk mencerminkan penggabungan saham dengan rasio 50 banding 1 dan 30 banding 1 yang masing-masing dilaksanakan pada 23 Maret 2026 dan 23 Juni 2026. Hasil keuangan semester pertama 2026 juga mencakup rugi bersih sebesar US$2,62 juta terkait obligasi konversi dan keuntungan bersih sebesar US$1,73 juta terkait liabilitas waran.

Kas bersih yang digunakan untuk aktivitas operasi tercatat sekitar US$10,99 juta pada semester pertama 2026, dibandingkan dengan US$0,63 juta pada periode yang sama tahun sebelumnya. Peningkatan ini terutama disebabkan oleh rugi operasional serta pelunasan utang usaha dan utang lainnya.

Kas bersih yang diperoleh dari aktivitas pendanaan selama semester pertama 2026 tercatat sekitar US$16,29 juta. Arus kas masuk dari aktivitas pendanaan mencakup sekitar US$18,55 juta yang berasal dari penerbitan saham biasa Kelas A sehubungan dengan penawaran saham At-The-Market (ATM) Perusahaan, serta hasil dari aktivitas pendanaan lainnya.

YYForce berencana mempertahankan pendekatan yang disiplin terhadap alokasi modal dengan menyeimbangkan kebutuhan modal kerja, kegiatan operasional yang sudah berjalan, dan investasi untuk mendukung pertumbuhan di masa depan.

Visi YYForce 2030 dan Strategi Alokasi Modal

Pada 22 September 2026, YYForce mengumumkan Visi 2030, sebuah peta jalan jangka panjang untuk membangun model Solusi Tenaga Kerja Masa Depan. Model ini mengintegrasikan kemampuan tenaga kerja manusia, manajemen tenaga kerja berkemampuan AI, teknologi manajemen fasilitas pintar, otomatisasi, dan robotika. Rencana ini dikembangkan berdasarkan bisnis Perusahaan yang sudah ada, yaitu aplikasi YY Circle dan Yolara AI untuk penyediaan tenaga kerja sesuai permintaan dan solusi tenaga kerja, serta robot humanoid dan robot layanan khusus yang ditawarkan melalui skema penyewaan dan Robotics-as-a-Service ("RaaS"). Rencana ini juga mencakup solusi manajemen fasilitas pintar melalui platform 24iFM, perangkat IoT, sensor, kamera pintar, dan teknologi otomatisasi. Yolara AI dirancang untuk mendukung perencanaan penempatan, integrasi alur kerja, koordinasi tim manusia, dan dukungan operasional berkelanjutan di seluruh solusi tersebut. Inisiatif AI, otomatisasi, dan robotika ini belum memberikan kontribusi yang signifikan terhadap pendapatan selama periode enam bulan yang berakhir pada 30 Juni 2026.

Prioritas utama YYForce dalam alokasi modal adalah mempertahankan likuiditas yang cukup untuk kegiatan operasional yang sudah berjalan, kebutuhan modal kerja, dan kewajiban kontraktualnya. Dengan tetap memperhatikan kebutuhan tersebut, Perusahaan dapat mengevaluasi investasi di berbagai bidang, termasuk teknologi manajemen tenaga kerja dan fasilitas pintar, pengembangan perangkat lunak, otomatisasi operasional, robotika komersial, infrastruktur data, ekspansi geografis, kemitraan strategis, dan akuisisi. Perusahaan berencana memanfaatkan kemitraan, skema penyewaan, dan program uji coba bersama pelanggan untuk membatasi kebutuhan modal awal. Setiap investasi akan dievaluasi berdasarkan permintaan pelanggan, kesiapan teknologi, dan tingkat imbal hasil yang diharapkan.

Proyeksi Kinerja Tahun Buku 2026

Mengingat tekanan biaya tenaga kerja pada semester pertama 2026, Perusahaan membatalkan proyeksi kinerja tahun buku 2026 yang diterbitkan pada 12 Maret 2026. Perusahaan berencana menyampaikan proyeksi terbaru bersama dengan pengumuman hasil keuangan tahun buku 2026. Investor tidak lagi dapat mengandalkan proyeksi yang diumumkan sebelumnya sebagai gambaran ekspektasi Perusahaan saat ini.

Tentang YYForce Inc.

YYForce Inc. (Nasdaq: YFOR) adalah penyedia platform manajemen tenaga kerja berkemampuan AI dan manajemen fasilitas terintegrasi (IFM), yang berkantor pusat di Singapura serta beroperasi di Asia dan wilayah lainnya. Platform solusi tenaga kerja cerdas milik Perusahaan, YY Circle, membantu klien di sektor perhotelan, makanan dan minuman, ritel, serta sektor jasa lainnya untuk memprediksi, merencanakan, dan mengoptimalkan penempatan tenaga kerja. Dalam bisnis IFM YYForce, platform perangkat lunak 24iFM dan portofolio anak perusahaan IFM yang komprehensif miliknya mendukung klien di sektor perhotelan, transportasi, perbankan, ritel, serta fasilitas serbaguna.

Dengan semakin berkembangnya kedua lini bisnis tersebut, Perusahaan secara sistematis mengintegrasikan kemampuan AI dan otomatisasi, dari dukungan pengambilan keputusan cerdas menuju manajemen tenaga kerja yang semakin otonom. Langkah ini bertujuan meningkatkan kualitas layanan, mengurangi biaya penempatan tenaga kerja, dan mendorong peningkatan margin dalam jangka panjang. YYForce, yang terdaftar di Nasdaq Capital Market, berkomitmen terhadap inovasi infrastruktur, pencapaian hasil yang terukur bagi klien, dan penciptaan nilai jangka panjang.

Pernyataan Berwawasan ke Depan

Siaran pers ini berisi pernyataan yang berwawasan ke depan dalam artian yang terkandung di Pasal 27A Securities Act tahun 1933, sebagaimana diubah, dan Pasal 21E Securities Exchange Act tahun 1934, sebagaimana diubah. Pernyataan berwawasan ke depan tersebut mencakup, antara lain, pernyataan mengenai Visi Tenaga Kerja Masa Depan 2030 YYForce; kinerja operasional dan keuangan di masa depan peningkatan margin; efisiensi operasional; perolehan kas; pengembangan teknologi; kecerdasan buatan; platform digital; manajemen fasilitas pintar; otomatisasi dan robotika; potensi penerapan robot humanoid; ekspansi geografis; akuisisi; kemitraan strategis; alokasi modal; peluang pendapatan berulang; serta komersialisasi produk dan layanan baru di masa depan. Perusahaan mendasarkan pernyataan berwawasan ke depan tersebut pada ekspektasi dan proyeksinya mengenai peristiwa di masa depan, yang disusun Perusahaan berdasarkan informasi yang tersedia saat ini bagi Perusahaan. Anda dapat mengidentifikasi pernyataan berwawasan ke depan dari sifatnya yang tidak berkaitan dengan peristiwa historis, terutama pernyataan yang menggunakan istilah seperti "mungkin," "seharusnya," "mengharapkan," "mengantisipasi," "mempertimbangkan," "memperkirakan," "meyakini," "merencanakan," "diproyeksikan," "memprediksi," "potensial," atau "berharap" maupun bentuk negatif dari istilah-istilah tersebut atau istilah serupa. Pernyataan berwawasan ke depan mengandung risiko dan ketidakpastian yang melekat sehingga peristiwa di masa depan yang dibahas dalam siaran pers ini mungkin tidak terjadi. Peristiwa dan hasil aktual dapat berbeda secara signifikan serta bergantung pada risiko, ketidakpastian, dan asumsi mengenai Perusahaan dan sejumlah faktor lainnya. Faktor-faktor tersebut termasuk, tetapi tidak terbatas pada, tujuan dan strategi Perusahaan; pengembangan bisnis, kondisi keuangan, dan hasil operasional Perusahaan di masa depan, termasuk peluncuran produk dan layanan baru, perkiraan perubahan pendapatan, biaya, dan pengeluaran Perusahaan, perkiraan pertumbuhan pelanggan, serta permintaan dan penerimaan pasar terhadap produk dan layanan Perusahaan; serta kondisi industri, pasar, dan regulasi, termasuk persaingan, kebijakan dan peraturan pemerintah yang memengaruhi industri Perusahaan, serta faktor lainnya yang dapat memengaruhi kondisi keuangan, likuiditas, dan hasil operasional Perusahaan. Untuk pembahasan lebih terperinci mengenai faktor-faktor risiko, silakan merujuk pada dokumen yang diserahkan Perusahaan kepada Komisi Sekuritas dan Bursa AS (SEC), termasuk bagian "Faktor Risiko" dalam laporan tahunan terbaru Perusahaan pada Formulir 20-F, sebagaimana telah diubah.

Ukuran Kinerja Keuangan Non-IFRS

Perusahaan menggunakan ukuran kinerja keuangan non-IFRS, seperti rugi/laba bersih non-IFRS, untuk mengevaluasi hasil operasional serta mengambil keputusan keuangan dan operasional. Perusahaan meyakini bahwa ukuran kinerja keuangan non-IFRS membantu mengidentifikasi tren mendasar dalam bisnis Perusahaan yang mungkin terdistorsi oleh dampak beban tertentu yang dicatat Perusahaan dalam hasil keuangan periode berjalan. Perusahaan meyakini bahwa ukuran kinerja keuangan non-IFRS memberikan informasi yang bermanfaat mengenai hasil operasionalnya, meningkatkan pemahaman secara menyeluruh terhadap kinerja masa lalu dan prospek masa depannya, serta memberikan gambaran yang lebih jelas mengenai metrik utama yang digunakan manajemen dalam pengambilan keputusan keuangan dan operasional. Ukuran kinerja keuangan non-IFRS memiliki keterbatasan sebagai alat analisis dan tidak boleh dipertimbangkan secara terpisah atau dianggap sebagai pengganti ukuran kinerja keuangan IFRS maupun ukuran kinerja lainnya, atau sebagai indikator kinerja operasional Perusahaan.

Ukuran kinerja keuangan non-IFRS Perusahaan tidak mencakup biaya konsultasi, beban terkait obligasi konversi, penyesuaian akuntansi satu kali, serta perubahan nilai wajar obligasi konversi dan liabilitas waran. Rekonsiliasi lengkap disajikan di bawah ini. Investor dianjurkan untuk menelaah rekonsiliasi tersebut bersama dengan laporan keuangan IFRS Perusahaan dan tidak hanya mengandalkan satu ukuran kinerja keuangan. Ukuran kinerja keuangan non-IFRS yang disajikan di sini mungkin tidak dapat dibandingkan dengan ukuran serupa yang menggunakan istilah yang sama oleh perusahaan lain. Perusahaan lain mungkin menghitung ukuran kinerja dengan nama yang serupa secara berbeda, sehingga membatasi kegunaannya sebagai ukuran pembanding terhadap data Perusahaan. Perusahaan menganjurkan investor dan pihak lainnya untuk menelaah informasi keuangannya secara menyeluruh dan tidak hanya mengandalkan satu ukuran kinerja keuangan.

Untuk informasi selengkapnya mengenai ukuran kinerja keuangan non-IFRS Perusahaan, silakan lihat bagian berjudul "Rekonsiliasi Ukuran Kinerja Keuangan IFRS dan Non-IFRS yang Belum Diaudit."

Unaudited Reconciliation of IFRS and Non-IFRS Financial Measures

US$	Six months ended June 30, 2026 (Unaudited)		Six months ended June 30, 2026 (Unaudited) Non-IFRS reconciliation
Revenue	32,659,236		32,659,236
Cost of revenue	(29,359,389	)	(29,008,975	)
Gross profit	3,299,847		3,650,261
Other income	703,883		703,883
Selling and marketing expenses	(1,152,522	)	(652,522	)
General and administrative expenses	(7,902,969	)	(6,286,830	)
Other expenses	(111,423	)	(111,423	)
Change in fair value of investment properties	(44,079	)	(44,079	)
Operating loss	(5,207,263	)	(2,740,710	)
Finance cost	(865,273	)	(452,773	)
Net loss on convertible notes designated at FVTPL	(2,617,807	)	-
Net gain on warrant liabilities	1,726,802		-
Loss before tax	(6,963,541	)	(3,193,483	)
Income tax expenses	(99,272	)	(99,272	)
Loss for the period	(7,062,813	)	(3,292,755	)
Foreign currency translation differences - foreign operations	(817,032	)	(817,032	)
Change in fair value of convertible notes designated at FVTPL due to own credit risk	1,726		1,726
Total comprehensive loss for the period	(7,878,119	)	(4,108,061	)
Loss attributable to:
Non-controlling interests	108,080		108,080
Equity owners of the Company	(7,170,893	)	(3,400,835	)

Reconciliation of Non-IFRS to IFRS Loss Attributable to Equity Owners

Loss attributable to equity owners of the Company ? non-IFRS	(3,400,835	)
Consultancy fees	(1,297,331	)
Convertible notes related expenses	(1,052,500	)
Net loss on convertible notes designated at FVTPL	(2,617,807	)
Net gain on warrant liabilities	1,726,802
One-time accounting adjustments	(529,222	)
Loss attributable to equity owners of the Company ? IFRS	(7,170,893	)

YYFORCE INC. AND ITS SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

	Note	June 30, 2026 (Unaudited)			December 31, 2025
		$			$
Assets
Current assets:
Cash			3,082,570			1,511,760
Trade receivables, net	4		11,063,513			12,138,342
Prepayment and other current assets	5		4,373,945			1,251,794
Amount due from related parties	18		4,054,010			501,637
Total current assets			22,574,038			15,403,533

Non-current assets:
Right-of-use assets	6		1,254,966			1,463,494
Intangible assets, net	8		5,017,595			5,174,257
Investment properties	9		2,381,942			2,445,292
Net investment in lease	10		-			2,970,685
Property and equipment, net	7		579,025			527,092
Financial assets measured at fair value through profit or loss ("FVTPL")			100,000			-
Prepayment and other non-current assets	5		179,151			422,849
Goodwill	8		5,808,574			5,808,574
Deferred tax assets			125,825			125,825
Total non-current assets			15,447,078			18,938,068

Total assets			38,021,116			34,341,601

Current liabilities:
Trade and other payables	11		4,572,651			10,837,525
Contract liabilities			572,280			-
Amount due to related parties	18		189,696			503,007
Lease liabilities, current	13		411,619			429,634
Convertible notes designated at FVTPL	12		14,379			-
Loans and borrowings, current	13		4,937,830			5,375,362
Total current liabilities			10,698,455			17,145,528

Non-current liabilities:
Loans and borrowings, non-current	13		367,687			627,526
Warrants liabilities	12		17,733			1,213,340
Deferred tax liabilities	17		645,722			645,722
Lease liabilities, non-current	13		928,611			1,099,767
Total non-current liabilities			1,959,753			3,586,355
Total liabilities			12,658,208			20,731,883

Equity
Share Capital*	14		43,966,842			24,825,837
Reserves	14		10,862,760			11,182,357
Accumulated deficit			(32,882,003	)		(25,711,110	)
Equity attributable to owners of the Company			21,947,599			10,297,084

Non-controlling interests			3,415,309			3,312,634
Total equity			25,362,908			13,609,718

Total liabilities and equity			38,021,116			34,341,601

Informasi mengenai saham dan nilai per saham disajikan secara retroaktif untuk mencerminkan reorganisasi tersebut.

YYFORCE INC. AND ITS SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE (LOSS) INCOME

		For the six months ended June 30,
	Note	2026 (Unaudited)			2025 (Unaudited)
		$			$
Revenue	16		32,659,236			25,754,473
Cost of revenue	16		(29,359,389	)		(21,486,338	)
Gross profit			3,299,847			4,268,135

Other income	16		703,883			814,457
Selling and marketing expenses	16		(1,152,522	)		(1,562,277	)
General and administrative expenses	16		(7,902,969	)		(7,107,000	)
Impairment loss on intangible asset	16		-			(4,063,000	)
Other expenses	16		(111,423	)		(31,918	)
Change in fair value of investment properties	16		(44,079	)		-
Operating loss			(5,207,263	)		(7,681,603	)

Finance cost	16		(865,273	)		(367,270	)
Net loss on convertible notes designated at FVTPL	12		(2,617,807	)		-
Net gain on warrant liabilities	12		1,726,802			(24,075	)
Loss before tax			(6,963,541	)		(8,072,948	)
Income tax expenses	17		(99,272	)		(123,038	)
Loss for the period			(7,062,813	)		(8,195,986	)
Other comprehensive (loss) income
Foreign currency translation differences ? foreign operations			(817,032	)		290,378
Change in fair value of convertible notes designated at FVTPL due to own credit risk			1,726			-
Total comprehensive loss for the period			(7,878,119	)		(7,905,608	)

Loss attributable to:
Equity owners of the Company			(7,170,893	)		(8,246,755	)
Non-controlling interests			108,080			50,769
Loss for the period			(7,062,813	)		(8,195,986	)

Total comprehensive loss attributable to:
Equity owners of the Company			(7,980,794	)		(7,963,848	)
Non-controlling interests			102,675			58,240
Total comprehensive loss for the period			(7,878,119	)		(7,905,608	)

Basic loss per share*	15		(13.62	)		(311.00	)
Diluted loss per share*	15		(13.62	)		(311.00	)
Weighted average number of shares
Basic			526,603			26,517
Diluted			526,603			26,517

* Informasi mengenai saham dan nilai per saham disajikan secara retroaktif untuk mencerminkan reorganisasi tersebut. Selain itu, jumlah saham biasa Kelas A disajikan secara retroaktif untuk mencerminkan penggabungan saham Perusahaan dengan rasio 50 banding 1 dan 30 banding 1 yang masing-masing dilaksanakan pada 23 Maret 2026 dan 23 Juni 2026.

From Warehouses to Sidewalks: Seyond Scales LiDAR for the Next Generation of Robotics

Sun, 27 Sep 2026 07:49:00 +0700

SUNNYVALE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- As the global robotics community gathers for the 2026 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), Seyond is highlighting a transformation already taking place beyond the research lab: robots are becoming an increasingly practical part of everyday life.

Across hospitals, warehouses, sidewalks, and commercial spaces, robots are taking on a growing range of real-world tasks. As the industry moves from prototypes and limited deployments toward broader commercialization, the challenge is no longer simply proving that a robot can navigate autonomously. It is doing so reliably, repeatedly and at meaningful scale.

Seyond is supporting this transition by bringing premium LiDAR technology to applications including healthcare and delivery robots, autonomous forklifts, AMRs, warehouse automation, humanoid robots, and other intelligent robotic platforms.

From Robotics Projects to Real-World Scale

The next wave of robotics growth is not being driven by a single type of robot.

In healthcare environments, autonomous mobile robots can transport medications, supplies, meals, and other materials throughout busy facilities. On sidewalks, delivery robots are bringing food and everyday goods directly to consumers. Across warehouses and logistics facilities, autonomous forklifts and AMRs are moving pallets, packages, and inventory alongside workers.

While these applications are different, they share a common challenge: robots must reliably understand and navigate dynamic environments designed around people.

For Seyond, the opportunity goes beyond supporting one or two robotics projects. As manufacturers move toward larger deployments, they need sensing technology that can meet production requirements without compromising the performance and reliability required for real-world autonomy.

Seyond's approach is centered on delivering premium LiDAR performance at production scale, balancing sensing performance, quality, integration, reliability, and scalability. With more than one million sensors delivered across its broader business, Seyond brings established manufacturing experience to a robotics market entering its next stage of growth.

Premium Perception, Built for Robotics

Seyond's robotics portfolio provides high-quality 3D sensing across different form factors, ranges, fields of view, and integration requirements.

The Hummingbird D1R, designed specifically for robotics applications, combines a compact form factor with a 140? ? 100? field of view and close-range detection, supporting robotic platforms that need broad environmental awareness within limited installation space.

Seyond is also continuing to expand its robotics sensing portfolio toward even smaller, lighter, and more energy-efficient form factors. These ultra-compact sensing solutions are being developed for emerging space- and power-constrained robotic platforms, where every gram, millimeter, and watt can matter.

As robots become smaller, more capable, and more integrated into everyday environments, Seyond is working to make high-quality 3D perception easier to integrate across an increasingly diverse range of robotic systems.

See Seyond at IROS 2026

At the 2026 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), Seyond will showcase its latest robotics sensing technologies and demonstrate how its LiDAR portfolio supports applications ranging from industrial automation and autonomous material handling to emerging robots designed to operate alongside people.

Visitors can meet the Seyond team at Booth 928 to explore how high-performance LiDAR can support the next generation of intelligent robotic systems.

The future of robotics will not be defined by a handful of prototypes, but by robots performing useful work at meaningful scale across the places where people live, work, receive care, and move through their day. Seyond is building the sensing technology to help make that transition possible.

About Seyond

Seyond is a global provider of advanced LiDAR solutions for automotive, robotics, and intelligent infrastructure applications. Focused on performance, reliability, and scalability, Seyond's LiDAR technologies enable real-world autonomy across diverse operating environments. The company is committed to accelerating the adoption of safe, intelligent, and connected systems through next-generation 3D sensing.